Colony Bankcorp (CBAN) 10-Q 15 May 20 2020 Q1 Quarterly report Financial data

Cover page

Cover page - shares	3 Months Ended
	Mar. 31, 2020	May 14, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	000-12436
Entity Registrant Name	COLONY BANKCORP, INC.
Entity Incorporation, State or Country Code	GA
Entity Tax Identification Number	58-1492391
Entity Address, Address Line One	115 South Grant Street
Entity Address, City or Town	Fitzgerald
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	31750
City Area Code	229
Local Phone Number	426-6000
Title of 12(b) Security	Common Stock, Par Value $1.00 per share
Trading Symbol	CBAN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		9,498,783
Entity Central Index Key	0000711669
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
ASSETS
Cash and due from banks	$ 20,616	$ 15,570
Interest-bearing deposits in banks	75,211	88,522
Cash and cash equivalents	95,827	104,092
Investment securities available for sale, at fair value	333,085	347,332
Other investments, at cost	3,891	4,288
Loans held for sale	11,022	10,076
Loans	989,026	968,814
Allowance for loan losses	(8,384)	(6,863)
Loans, net	980,642	961,951
Premises and equipment	32,515	32,482
Other real estate	847	1,320
Goodwill	16,477	16,477
Other intangible assets	2,883	3,056
Bank-owned life insurance	21,785	21,629
Other assets	11,074	12,610
Total assets	1,510,048	1,515,313
Deposits
Noninterest-bearing	235,269	232,635
Interest-bearing	1,057,807	1,061,107
Total deposits	1,293,076	1,293,742
Subordinated debentures	24,229	24,229
Other borrowings	51,063	61,563
Other liabilities	5,608	5,273
Total liabilities	1,373,976	1,384,807
Stockholders' equity:
Preferred stock, no par value; 10,000,000 shares authorized, none issued or outstanding as of March 31, 2020 and December 31, 2019, respectively	0	0
Common stock, par value $1.00 per share; 20,000,000 shares authorized, 9,498,783 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively	9,499	9,499
Paid in capital	43,675	43,667
Retained earnings	77,631	76,978
Accumulated other comprehensive income, net of tax	5,267	362
Total stockholders' equity	136,072	130,506
Total liabilities and stockholders' equity	$ 1,510,048	$ 1,515,313

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred Stock, No Par Value (in dollars per share)	$ 0	$ 0
Preferred Stock, Shares Authorized (in shares)	10,000,000	10,000,000
Preferred Stock, Shares Issued (in shares)	0	0
Preferred Stock, Shares Outstanding (in shares)	0	0
Common Stock, Par Value (in dollars per share)	$ 1	$ 1
Common Stock, Shares Authorized (in shares)	20,000,000	20,000,000
Common Stock, Shares, Issued (in shares)	9,498,783	9,498,783
Common Stock, Shares, Outstanding (in shares)	9,498,783	9,498,783

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Interest Income
Loans, including fees	$ 13,290	$ 10,470
Investment securities	1,994	2,261
Deposits with other banks and short term investments	284	282
Total interest income	15,568	13,013
Interest expense
Deposits	2,218	2,122
Federal Home Loan Bank Advances	257	260
Other borrowings	389	274
Total interest expense	2,864	2,656
Net interest income	12,704	10,357
Provision for loan losses	1,956	131
Net interest income after provision for loan losses	10,748	10,226
Noninterest income
Gain on sale of SBA loans	210	0
Gain on sale of securities	293	0
Other	229	327
Total noninterest income	4,561	2,334
Noninterest Expenses
Salaries and employee benefits	7,498	5,371
Occupancy and equipment	1,318	1,025
Acquisition related expenses	287	128
Other	4,275	2,502
Total noninterest expense	13,378	9,026
Income before income taxes	1,931	3,534
Income taxes	328	699
Net income	$ 1,603	$ 2,835
Net income per share of common stock
Basic (in dollars per share)	$ 0.17	$ 0.34
Diluted (in dollars per share)	0.17	0.34
Cash Dividends Paid Per Share of Common Stock (in dollars per share)	$ 0.10	$ 0.08
Weighted Average Basic Shares Outstanding (in shares)	9,498,783	8,440,357
Weighted Average Diluted Shares Outstanding (in shares)	9,498,783	8,440,357
Service charges on deposits
Noninterest income
Non interest revenue from banking services	$ 1,304	$ 964
Other service charges, commissions and fees
Noninterest income
Non interest revenue from banking services	1,263	900
Mortgage fee income
Noninterest income
Non interest revenue from banking services	$ 1,262	$ 143

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 1,603	$ 2,835
Other comprehensive income:
Unrealized gains on securities arising during the period	6,501	4,004
Tax effect	(1,365)	(841)
Realized (gains) on sale of available for sale securities	(293)	0
Tax effect	62	0
Change in unrealized gains on securities available for sale, net of reclassification adjustment and tax effects	4,905	3,163
Comprehensive income	$ 6,508	$ 5,998

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning Balance (in shares) at Dec. 31, 2018		8,445
Beginning Balance at Dec. 31, 2018	$ 95,692	$ 8,445	$ 25,978	$ 69,459	$ (8,190)
Change in net unrealized gains on securities available for sale, net of reclassification adjustment and tax effects	3,163				3,163
Dividends on common shares ($0.075 per share)	(633)			(633)
Stock-based compensation expense	9		9
Net income	2,835			2,835
Ending Balance (in shares) at Mar. 31, 2019		8,445
Ending Balance at Mar. 31, 2019	101,066	$ 8,445	25,987	71,661	(5,027)
Beginning Balance (in shares) at Dec. 31, 2019		9,499
Beginning Balance at Dec. 31, 2019	130,506	$ 9,499	43,667	76,978	362
Change in net unrealized gains on securities available for sale, net of reclassification adjustment and tax effects	4,905				4,905
Dividends on common shares ($0.075 per share)	(950)			(950)
Stock-based compensation expense	8		8
Net income	1,603			1,603
Ending Balance (in shares) at Mar. 31, 2020		9,499
Ending Balance at Mar. 31, 2020	$ 136,072	$ 9,499	$ 43,675	$ 77,631	$ 5,267

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 1,603	$ 2,835
Provided by operating activities:
Provision for loan losses	1,956	131
Depreciation, amortization, and accretion	140	686
Share-based compensation expense	8	9
Gain on sale of securities	(293)	0
Gain on sale of SBA loans	(210)	0
Loss on sale of other real estate	125	5
Loss (gain)on sale of premises & equipment	18	(2)
Originations of loans held for sale	(30,093)	0
Proceeds from sales of loans held for sale	29,357	0
Change in bank-owned life insurance	(156)	414
Change in other assets	525	834
Change in other liabilities	335	272
Net cash provided by operating activities	3,315	5,184
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of investment securities available for sale	(14,454)	(14,119)
Proceeds from maturities, calls, and paydowns of investment securities available for sale	20,022	13,065
Proceeds from sale of investment securities	15,314	0
Net loans	(20,932)	1,085
Purchase of premises and equipment	(649)	(1,152)
Proceeds from sale of other real estate	813	351
Redemption (purchase of) Federal Home Loan Bank Stock	397	195
Proceeds from sale of premises and equipment	25	22
Net cash (used in) provided by investing activities	536	(553)
CASH FLOWS FROM FINANCING ACTIVITIES
Increase in noninterest-bearing customer deposits	2,634	6,637
(Decrease) increase in interest-bearing customer deposits	(3,300)	19,915
Dividends paid for common stock	(950)	(633)
Payments on Federal Home Loan Bank Advances	(24,500)	(5,000)
Proceeds from Federal Home Loan Bank Advances	14,000	0
Net cash (used in) provided by financing activities	(12,116)	20,919
Net (decrease) increase in cash and cash equivalents	(8,265)	25,550
Cash and cash equivalents at beginning of period	104,092	60,155
Cash and cash equivalents at end of period	95,827	85,705
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid during the period for interest	5,857	5,772
Cash paid during the period for income taxes	0	2,220
NONCASH INVESTING AND FINANCING ACTIVITIES
Acquisition of real estate through foreclosure	$ 465	$ 756

Loans

Loans	3 Months Ended
	Mar. 31, 2020
Receivables [Abstract]
Loans	Loans The following table presents the composition of loans segregated by legacy and purchased loans and by class of loans, as of March 31, 2020 and December 31, 2019. Purchased loans are defined as loans that were acquired in bank acquisitions. March 31, 2020 (dollars in thousands) Legacy Loans Purchased Loans Total Construction, land and land development $ 86,268 $ 47,769 $ 134,037 Other commercial real estate 466,761 57,723 524,484 Total commercial real estate 553,029 105,492 658,521 Residential real estate 169,199 21,770 190,969 Commercial, financial, & agricultural 99,121 17,665 116,786 Consumer and other 19,303 3,447 22,750 Total Loans $ 840,652 $ 148,374 $ 989,026 December 31, 2019 (dollars in thousands) Legacy Loans Purchased Loans Total Construction, land and land development $ 83,036 $ 13,061 $ 96,097 Other commercial real estate 481,943 58,296 540,239 Total commercial real estate 564,979 71,357 636,336 Residential real estate 171,341 23,455 194,796 Commercial, financial, & agricultural 91,535 22,825 114,360 Consumer and other 19,245 4,077 23,322 Total Loans $ 847,100 $ 121,714 $ 968,814 Commercial and industrial loans are extended to a diverse group of businesses within the Company’s market area. These loans are often underwritten based on the borrower’s ability to service the debt from income from the business. Real estate construction loans often require loan funds to be advanced prior to completion of the project. Due to uncertainties inherent in estimating construction costs, changes in interest rates and other economic conditions, these loans often pose a higher risk than other types of loans. Consumer loans are originated at the Bank level. These loans are generally smaller loan amounts spread across many individual borrowers to help minimize risk. Credit Quality Indicators . As part of the ongoing monitoring of the credit quality of the loan portfolio, management tracks certain credit quality indicators including trends related to (1) the risk grade assigned to commercial and consumer loans, (2) the level of classified commercial loans, (3) net charge-offs, (4) nonperforming loans, and (5) the general economic conditions in the Company’s geographic markets. The Company uses a risk grading matrix to assign a risk grade to each of its loans. Loans are graded on a scale of 1 to 8. A description of the general characteristics of the grades is as follows: • Grades 1 and 2 – Borrowers with these assigned grades range in risk from virtual absence of risk to minimal risk. Such loans may be secured by Company-issued and controlled certificates of deposit or properly margined equity securities or bonds. Other loans comprising these grades are made to companies that have been in existence for a long period of time with many years of consecutive profits and strong equity, good liquidity, excellent debt service ability and unblemished past performance, or to exceptionally strong individuals with collateral of unquestioned value that fully secures the loans. Loans in this category fall into the “pass” classification. • Grades 3 and 4 – Loans assigned these “pass” risk grades are made to borrowers with acceptable credit quality and risk. The risk ranges from loans with no significant weaknesses in repayment capacity and collateral protection to acceptable loans with one or more risk factors considered to be more than average. • Grade 5 – This grade includes “special mention” loans on management’s watch list and is intended to be used on a temporary basis for pass grade loans where risk-modifying action is intended in the short-term. • Grade 6 – This grade includes “substandard” loans in accordance with regulatory guidelines. This category includes borrowers with well-defined weaknesses that jeopardize the payment of the debt in accordance with the agreed terms. Loans considered to be impaired are assigned this grade, and these loans often have assigned loss allocations as part of the allowance for loan and lease losses. Generally, loans on which interest accrual has been stopped would be included in this grade. • Grades 7 and 8 – These grades correspond to regulatory classification definitions of “doubtful” and “loss,” respectively. In practice, any loan with these grades would be for a very short period of time, and generally the Company has no loans with these assigned grades. Management manages the Company’s problem loans in such a way that uncollectible loans or uncollectible portions of loans are charged off immediately with any residual, collectible amounts assigned a risk grade of 6. The following table presents the loan portfolio, excluding purchased loans, by credit quality indicator (risk grade) as of March 31, 2020 and December 31, 2019. Those loans with a risk grade of 1, 2, 3 or 4 have been combined in the pass column for presentation purposes. For the period ending March 31, 2020 and December 31, 2019, the Company did not have any loans classified as “doubtful” or a “loss”. (dollars in thousands) Pass Special Mention Substandard Total Loans March 31, 2020 Construction, land and land development $ 85,515 $ 431 $ 322 $ 86,268 Other commercial real estate 445,603 11,123 10,035 466,761 Total commercial real estate 531,118 11,554 10,357 553,029 Residential real estate 157,935 4,496 6,768 169,199 Commercial, financial, & agricultural 94,465 1,713 2,943 99,121 Consumer and other 18,927 178 198 19,303 Total Loans $ 802,445 $ 17,941 $ 20,266 $ 840,652 (dollars in thousands) December 31, 2019 Construction, land and land development $ 82,322 $ 445 $ 269 $ 83,036 Other commercial real estate 459,064 13,438 9,441 481,943 Total commercial real estate 541,386 13,883 9,710 564,979 Residential real estate 159,194 4,632 7,515 171,341 Commercial, financial, & agricultural 86,558 1,973 3,004 91,535 Consumer and other 18,883 148 214 19,245 Total Loans $ 806,021 $ 34,519 $ 20,443 $ 847,100 The following table presents the purchased loan portfolio by credit quality indicator (risk grade) as of March 31, 2020 and December 31, 2019. Those loans with a risk grade of 1, 2, 3 or 4 have been combined in the pass column for presentation purposes. For the period ending March 31, 2020, the Company did not have any loans classified as “doubtful” or a “loss”. (dollars in thousands) Pass Special Mention Substandard Total Loans March 31, 2020 Construction, land and land development $ 45,953 $ 1,698 $ 118 $ 47,769 Other commercial real estate 54,900 579 2,244 57,723 Total commercial real estate 100,853 2,277 2,362 105,492 Residential real estate 21,348 307 115 21,770 Commercial, financial, & agricultural 14,525 2,981 159 17,665 Consumer and other 3,256 — 191 3,447 Total Loans $ 139,982 $ 5,565 $ 2,827 $ 148,374 December 31, 2019 Construction, land and land development $ 12,996 $ — $ 65 $ 13,061 Other commercial real estate 57,881 381 34 58,296 Total commercial real estate 70,877 381 99 71,357 Residential real estate 23,097 249 109 23,455 Commercial, financial, & agricultural 19,443 2,949 433 22,825 Consumer and other 4,077 — — 4,077 Total Loans $ 117,494 $ 3,579 $ 641 $ 121,714 A loan’s risk grade is assigned at the inception of the loan and is based on the financial strength of the borrower and the type of collateral. Loan risk grades are subject to reassessment at various times throughout the year as part of the Company’s ongoing loan review process. Loans with an assigned risk grade of 6 or below and an outstanding balance of $250,000 or more are reassessed on a quarterly basis. During this reassessment process individual reserves may be identified and placed against certain loans which are not considered impaired. In assessing the overall economic condition of the markets in which it operates, the Company monitors the unemployment rates for its major service areas. The unemployment rates are reviewed on a quarterly basis as part of the allowance for loan loss determination. Loans are considered past due if the required principal and interest payments have not been received as of the date such payments were due. Generally, loans are placed on nonaccrual status if principal or interest payments become 90 days past due or when, in management’s opinion, the borrower may be unable to meet payment obligations as they become due, as well as when required by regulatory provision. Loans may be placed on nonaccrual status regardless of whether or not such loans are considered past due. The following table represents an age analysis of past due loans and nonaccrual loans for legacy loans, segregated by class of loans, excluding purchased loans as of March 31, 2020 and December 31, 2019: Accruing Loans (dollars in thousands) 30-89 Days 90 Days Total Accruing Nonaccrual Current Loans Total Loans March 31, 2020 Construction, land and land development $ 293 $ — $ 293 $ 81 $ 85,894 $ 86,268 Other commercial real estate 1,390 — 1,390 3,805 461,566 466,761 Total commercial real estate 1,683 — 1,683 3,886 547,460 553,029 Residential real estate 1,635 — 1,635 3,336 164,228 169,199 Commercial, financial, & agricultural 531 — 531 2,779 95,811 99,121 Consumer and other 113 — 113 129 19,061 19,303 Total Loans $ 3,962 $ — $ 3,962 $ 10,130 $ 826,560 $ 840,652 December 31, 2019 Construction, land and land development $ 50 $ — $ 50 $ 32 $ 82,954 $ 83,036 Other commercial real estate 335 — 335 3,738 477,870 481,943 Total commercial real estate 385 — 385 3,770 560,824 564,979 Residential real estate 1,296 — 1,296 3,643 166,402 171,341 Commercial, financial, & agricultural 212 — 212 1,628 89,695 91,535 Consumer and other 21 — 21 138 19,086 19,245 Total Loans $ 1,914 $ — $ 1,914 $ 9,179 $ 836,007 $ 847,100 The following table represents an age analysis of past due loans and nonaccrual loans, segregated by class of loans, for purchased loans as of March 31, 2020 and December 31, 2019: Accruing Loans (dollars in thousands) 30-89 Days 90 Days Total Accruing Nonaccrual Current Loans Total Loans March 31, 2020 Construction, land and land development $ 679 $ — $ 679 $ — $ 47,090 $ 47,769 Other commercial real estate — — — — 57,723 57,723 Total commercial real estate 679 — 679 — 104,813 105,492 Residential real estate — — — — 21,770 21,770 Commercial, financial, & agricultural — — — — 17,665 17,665 Consumer and other 4 — 4 — 3,443 3,447 Total Loans $ 683 $ — $ 683 $ — $ 147,691 $ 148,374 December 31, 2019 Construction, land and land development $ — $ — $ — $ — $ 13,061 $ 13,061 Other commercial real estate 83 — 83 — 58,213 58,296 Total commercial real estate 83 — 83 — 71,274 71,357 Residential real estate 57 — 57 — 23,398 23,455 Commercial, financial, & agricultural 553 — 553 — 22,272 22,825 Consumer and other 8 — 8 — 4,069 4,077 Total Loans $ 701 $ — $ 701 $ — $ 121,013 $ 121,714 The following table details impaired loan data, including purchased credit impaired loans, as of March 31, 2020. (dollars in thousands) March 31, 2020 Unpaid Impaired Related Average With No Related Allowance Recorded Construction, land and land development $ 66 $ 66 $ — $ 67 Commercial real estate 13,124 12,259 — 12,357 Residential real estate 2,477 2,465 — 2,586 Commercial, financial & agriculture 381 381 — 319 Consumer & other — — — — 16,048 15,171 — 15,329 With An Allowance Recorded Construction, land and land development — — — — Commercial real estate 6,336 6,336 2,077 6,358 Residential real estate 525 525 99 641 Commercial, financial & agriculture 1,974 1,974 981 2,082 Consumer & other — — — — 8,835 8,835 3,157 9,081 Purchased Credit Impaired Loans Construction, land and land development 119 119 — 92 Commercial real estate 125 125 — 79 Residential real estate 18 18 12 15 Commercial, financial & agriculture 62 62 — 49 Consumer & other 191 191 88 95 515 515 100 330 Total Construction, land and land development 185 185 — 159 Commercial real estate 19,585 18,720 2,077 18,794 Residential real estate 3,020 3,008 111 3,242 Commercial, financial & agriculture 2,417 2,417 981 2,450 Consumer & other 191 191 88 95 $ 25,398 $ 24,521 $ 3,257 $ 24,740 The following table details impaired loan data as of December 31, 2019. (dollars in thousands) December 31, 2019 Unpaid Impaired Related Average With No Related Allowance Recorded Construction, land and land development $ 67 $ 67 $ — $ 168 Commercial real estate 12,455 11,639 — 13,924 Residential real estate 2,706 2,711 — 3,693 Commercial, financial & agriculture 257 257 910 Consumer & other — — — 123 15,485 14,674 — 18,818 With An Allowance Recorded Construction, land and land development — — — 80 Commercial real estate 6,379 6,385 1,939 3,898 Residential real estate 757 760 137 367 Commercial, financial & agriculture 2,189 1,989 1,073 722 Consumer & other — — — — 9,325 9,134 3,149 5,067 Purchased Credit Impaired Loans Construction, land and land development 65 65 — 80 Commercial real estate 34 34 — 35 Residential real estate 11 11 6 24 Commercial, financial & agriculture 37 37 — 47 Consumer & other — — — — 147 147 6 186 Total Construction, land and land development 132 132 — 328 Commercial real estate 18,868 18,058 1,939 17,857 Residential real estate 3,474 3,482 143 4,084 Commercial, financial & agriculture 2,483 2,283 1,073 1,679 Consumer & other — — — 123 24,957 23,955 3,155 24,071 Interest income recorded on impaired loans during the three months ended March 31, 2020 and 2019 was $50,000, and $43,000 reflects interest income recorded on nonaccrual loans prior to them being placed on nonaccrual status and interest income recorded on TDRs. TDRs are troubled loans on which the original terms of the loan have been modified in favor of the borrower due to deterioration in the borrower’s financial condition. Each potential loan modification is reviewed individually and the terms of the loan are modified to meet the borrower’s specific circumstances at a point in time. Not all loan modifications are TDRs. Loan modifications are reviewed and approved by the Company’s senior lending staff, who then determine whether the loan meets the criteria for a TDR. Generally, the types of concessions granted to borrowers that are evaluated in determining whether a loan is classified as a TDR include: • Interest rate reductions – Occur when the stated interest rate is reduced to a nonmarket rate or a rate the borrower would not be able to obtain elsewhere under similar circumstances. • Amortization or maturity date changes – Result when the amortization period of the loan is extended beyond what is considered a normal amortization period for loans of similar type with similar collateral. • Principal reductions – These are often the result of commercial real estate loan workouts where two new notes are created. The primary note is underwritten based upon our normal underwriting standards and is structured so that the projected cash flows are sufficient to repay the contractual principal and interest of the newly restructured note. The terms of the secondary note vary by situation and often involve that note being charged-off, or the principal and interest payments being deferred until after the primary note has been repaid. In situations where a portion of the note is charged-off during modification there is often no specific reserve allocated to those loans. This is due to the fact that the amount of the charge-off usually represents the excess of the original loan balance over the collateral value and the Company has determined there is no additional exposure on those loans. As discussed in Note 1 of the Notes to Consolidated Financial Statements for the year ended December 31, 2019, which are included in the Company’s 2019 Form 10-K, once a loan is identified as a TDR, it is accounted for as an impaired loan. The Company had no unfunded commitments to lend to a customer that has a troubled debt restructured loan as of March 31, 2020. The Company had no loan contracts restructured during the three month period ended March 31, 2020 and 2019. Loans modified in a troubled debt restructuring are considered to be in default once the loan becomes 90 days past due. A TDR may cease being classified as impaired if the loan is subsequently modified at market terms and, has performed according to the modified terms for at least six months, and there has not been any prior principal forgiveness on a cumulative basis. The Company had no loans that subsequently defaulted during the three months ended March 31, 2020 and 2019. Modifications in Response to COVID-19

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares	Mar. 31, 2020	Mar. 31, 2019
Statement of Stockholders' Equity [Abstract]
Dividends on common shares (in dollars per share)	$ 0.075	$ 0.10

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Presentation Colony Bankcorp, Inc. (the “Company”) is a bank holding company located in Fitzgerald, Georgia. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Colony Bank, Fitzgerald, Georgia (the “Bank”). The “Company” or “our,” as used herein, includes Colony Bank. In July 2019, a new subsidiary of the Company was incorporated under the name Colony Risk Management, Inc. Colony Risk Management, Inc. is a subsidiary of the Company and is located in Las Vegas, Nevada. It is a captive insurance subsidiary which insures various liability and property damage policies for the Company and its related subsidiaries. Colony Risk Management is regulated by the State of Nevada Division of Insurance. All dollars in notes to consolidated financial statements are rounded to the nearest thousands, except for per share amounts. The consolidated financial statements in this report are unaudited, except for the December 31, 2019 consolidated balance sheet. All adjustments consisting of normal recurring accruals which are, in the opinion of management, necessary for fair presentation of the interim consolidated financial statements, have been included and fairly and accurately present the financial position, results of operations and cash flows of the Company. All significant intercompany accounts have been eliminated in consolidation. The accounting and reporting policies of the Company conform to generally accepted accounting principles and practices utilized in the commercial banking industry for interim financial information and Regulation S-X. Accordingly, they do not include all of the information or notes required for complete financial statements. The results of operations for the three months ended March 31, 2020 are not necessarily indicative of the results which may be expected for the year ending December 31, 2020. These statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2019 in the Company's 2019 10-K. The Company’s significant accounting policies are described in Note 1 of the Notes to Consolidated Financial Statements for the year ended December 31, 2019, which are included in the Company’s 2019 Form 10-K. For interim reporting purposes, the Company follows the same basic accounting policies and considers each interim period as an integral part of an annual period. Nature of Operations The Bank provides a full range of retail, commercial and mortgage banking services for consumers and small- to medium-size businesses located primarily in central, south and coastal Georgia. The Bank is headquartered in Fitzgerald, Georgia with banking and mortgage offices in Albany, Ashburn, Athens, Broxton, Centerville, Columbus, Cordele, Douglas, Eastman, Fitzgerald, LaGrange, Leesburg, Macon, Moultrie, Quitman, Rochelle, Savannah, Soperton, Sylvester, Statesboro, Thomaston, Tifton, Valdosta and Warner Robins. Lending and investing activities are funded primarily by deposits gathered through its retail banking office network. Use of Estimates In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet date and revenues and expenses for the period. Actual results could differ significantly from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, the valuation of real estate acquired in connection with foreclosures or in satisfaction of loans and fair value of assets acquired and liabilities assumed in a business combination. Reclassifications In certain instances, amounts reported in prior years’ consolidated financial statements have been reclassified to conform to statement presentations selected for 2020. Such reclassifications have not materially affected previously reported stockholders’ equity or net income. Concentrations of Credit Risk Concentrations of credit risk can exist in relation to individual borrowers or groups of borrowers, certain types of collateral, certain types of industries, or certain geographic regions. The Company has a concentration in real estate loans as well as a geographic concentration that could pose an adverse credit risk. At March 31, 2020, approximately 86% of the Company’s loan portfolio was concentrated in loans secured by real estate. A substantial portion of borrowers’ ability to honor their contractual obligations is dependent upon the viability of the real estate economic sector. Management continues to monitor these concentrations and has considered these concentrations in its allowance for loan loss analysis. Concentrations of Credit Risk (Continued) The success of the Company is dependent, to a certain extent, upon the economic conditions in the geographic markets it serves. Adverse changes in the economic conditions in these geographic markets would likely have a material adverse effect on the Company’s results of operations and financial condition. The operating results of the Company depend primarily on its net interest income. Accordingly, operations are subject to risks and uncertainties surrounding the exposure to changes in the interest rate environment. At times, the Company may have cash and cash equivalents at financial institutions in excess of federal deposit insurance limits. The Company places its cash and cash equivalents with high credit quality financial institutions whose credit ratings are monitored by management to minimize credit risk. Changes in Accounting Principles and Effects of New Accounting Pronouncements ASU 2016-13, Financial Instruments – Credit Losses (Topic 326). This ASU sets forth a “current expected credit loss” (CECL) model which requires the Company to measure all expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable supported forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost and applies to some off-balance sheet credit exposures. This ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. On October 16, 2019, FASB voted to extend the delay of the effective date of this ASU for smaller reporting companies, such as the Company, until fiscal years beginning after December 15, 2022. The Company is currently assessing the impact of the adoption of this ASU on its consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This update removes several exceptions related to intraperiod tax allocation when there is a loss from continuing operations and income from other items, foreign subsidiaries becoming equity method investments and vice versa, and calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. The guidance also amends requirements related to franchise tax that is partially based on income, a step up in the tax basis of goodwill, allocation of consolidated tax expense to a legal entity not subject to tax in its separate financial statements, the effects of enacted changes in tax laws and other minor codification improvements regarding employee stock ownership plans and investments in qualified affordable housing projects. For public entities, this guidance is effective for fiscal years beginning after December 15, 2020. The Company does not expect the new guidance to have a material impact on the consolidated financial statements. In January 2020, the FASB issued ASU No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is effective for fiscal years beginning after December 15, 2020. The Company does not expect the new guidance to have a material impact on the consolidated financial statements. In March 2020, the FAS issued ASU No. 2020-04 "Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting" ("ASU 2020-04"). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of ) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not believe this standard will have a material impact on its consolidated financial statements. Operating, Accounting and Reporting Considerations Related to COVID-19 The COVID-19 pandemic has negatively impacted the global economy, including the Company’s primary metropolitan markets. In response to this crisis, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was passed by Congress and signed into law on March 27, 2020. The CARES Act provides an estimated $2.2 trillion to fight the COVID-19 pandemic and stimulate the economy by supporting individuals and businesses through loans, grants, tax changes, and other types of relief. Some of the provisions applicable to the Company include, but are not limited to: • Accounting for Loan Modifications - The CARES Act provides that financial institutions may elect to suspend (1) the requirements under GAAP for certain loan modifications that would otherwise by categorized as a troubled debt restructure (“TDR”) and (2) any determination that such loan modifications would be considered a TDR, including the related impairment for accounting purposes. • Pay Protection Program - The CARES Act established the Paycheck Protection Program (“PPP”), an expansion of the Small Business Administration’s 7(a) loan program and the Economic Injury Disaster Loan Program (“EIDL”), administered directly by the SBA. Also in response to the COVID-19 pandemic, the Board of Governors of the Federal Reserve System (“FRB”), the Federal Deposit Insurance Corporation (“FDIC”), the National Credit Union Administration (“NCUA”), the Office of the Comptroller of the Currency (“OCC”), and the Consumer Financial Protection Bureau (“CFPB”), in consultation with the state financial regulators (collectively, the “agencies”) issued a joint interagency statement (issued March 22, 2020; revised statement issued April 7, 2020). Some of the provisions applicable to the Company include, but are not limited to: • Accounting for Loan Modifications - Loan modifications that do not meet the conditions of the CARES Act may still qualify as a modification that does not need to be accounted for as a TDR. The agencies confirmed with FASB staff that short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief are not TDRs. This includes short-term (e.g., three months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or insignificant delays in payment, as long as such modifications are (1) related to COVID-19; (2) executed on a loan that was not more than 30 days past due as of December 31, 2019; and (3) executed between March 1, 2020, and the earlier of (a) 60 days after the date of termination of the national emergency declaration or (b) December 31, 2020. • Past Due Reporting - With regard to loans not otherwise reportable as past due, financial institutions are not expected to designate loans with deferrals granted due to COVID-19 as past due because of the deferral. A loan’s payment date is governed by the due date stipulated in the legal agreement. If a financial institution agrees to a payment deferral, these loans would not be considered past due reporting during the period of the deferral. • Nonaccrual Status and Charge-offs - During short-term COVID-19 modifications, these loans generally should not be reported as nonaccrual or as classified.

Business Acquisitions

Business Acquisitions	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Business Acquisitions	Business Acquisitions Acquisition of LBC Bancshares, Inc. On May 1, 2019, the Company completed its acquisition of LBC Bancshares, Inc. (“LBC”), a bank holding company headquartered in LaGrange, Georgia. Upon consummation of the acquisition, LBC was merged with and into the Company, with Colony as the surviving entity in the merger. At that time, LBC’s wholly owned bank subsidiary, Calumet Bank, was also merged with and into the Bank. The acquisition expanded the Company’s market presence, as Calumet Bank had two full-service banking locations, one each in LaGrange, Georgia and Columbus, Georgia, as well as a loan production office in Atlanta, Georgia. Under the terms of the Agreement and Plan of Merger, each LBC shareholder had the option to receive either $23.50 in cash or 1.3239 shares of the Company’s common stock in exchange for each share of LBC common stock, subject to customary proration and allocation procedures such that 55% of LBC shares received the stock consideration and 45% received the cash consideration, with at least 50% of the merger consideration paid in the Company's common stock. As a result, the Company issued 1,053,875 common shares at a fair value of $18.7 million and paid $15.3 million in cash to the former shareholders of LBC as merger consideration. The merger was effected by the issuance of shares of the Company’s common stock along with cash consideration to shareholders to LBC. The assets and liabilities of LBC as of the effective date of the merger were recorded at their respective estimated fair values and combined with those of the Company. The excess of the purchase price over the net estimated fair values of the acquired assets and liabilities was allocated to identifiable intangible assets with the remaining excess allocated to goodwill. Goodwill of $15.7 million was recorded as part of the LBC acquisition and is not expected to be deductible for income tax purposes. The following table presents the assets acquired and liabilities assumed of LBC as of May 1, 2019, and their fair value estimates. The fair value estimates were subject to refinement for up to one year after the closing date of the acquisition for new information obtained about facts and circumstances that existed at the acquisition date. The Company continues its evaluation of the facts and circumstances available as of May 1, 2019, to assign fair values to assets acquired and liabilities assumed, which could result in further adjustments to the fair values presented below. Purchase price consideration (dollars in thousands): Shares of CBAN common stock issued to LBC shareholders as of May 1, 2019 1,053,875 Market price of CBAN common stock on May 1, 2019 $ 17.75 Estimated fair value of CBAN common stock issued 18,706 Cash consideration paid 15,315 Total consideration $ 34,021 Assets acquired at fair value: Cash and cash equivalents $ 15,678 Investments securities available for sale 49,172 Investments securities held to maturity 1,766 Restricted investments 479 Loans 130,568 Premises and equipment 3,009 Core deposit intangible 3,100 Other real estate 243 Prepaid and other assets 6,143 Total fair value of assets acquired $ 210,158 Liabilities assumed at fair value: Deposits $ (189,896) FHLB advances (1,000) Payables and other liabilities (975) Total fair value of liabilities assumed $ (191,871) Net assets acquired at fair value: $ 18,287 Amount of goodwill resulting from acquisition $ 15,734 In the acquisition, the Company purchased $130.6 million of loans at fair value, net of $2.2 million, or 1.63%, estimated discount to the outstanding principal balance. Of the total loans acquired, management identified $176,000 that were considered to be credit impaired and are accounted for under ASC Topic 310-30. The table below summarizes the total contractually required principal and interest cash payments, management’s estimate of expected total cash payments and fair value of the loans as of the acquisition date for purchased credit impaired loans. Contractually required principal and interest payments have been adjusted for estimated prepayments. (dollars in thousands) Contractually required principal and interest $ 695 Non-accretable difference (519) Cash Flows expected to be collected 176 Accretable yield — Total purchased credit-impaired loans acquired $ 176 The following table presents the acquired loan data for the LBC acquisition. (dollars in thousands) Fair Value of Gross Contractual Estimate at Acquired receivables subject to ASC 310-30 $ 176 $ 695 $ 519 Acquired receivables not subject to ASC 310-30 130,392 132,381 — Acquisition of PFB Mortgage from Planters First Bank On May 1, 2019, the Bank completed its acquisition of PFB Mortgage, the secondary market mortgage business of Planters First Bank for a total cash consideration of $833,000.The assets acquired included premises and equipment as well as all pipeline loans. The assets acquired were recorded at their respective estimated fair values as of the effective date of the transaction. The excess of the purchase price over fair value of net assets acquired was allocated to goodwill. The following table presents the assets acquired as of May 1, 2019, and their fair value estimates. The fair value estimates were subject to refinement for up to one year after the closing date of the acquisition for new information obtained about facts and circumstances that existed at the acquisition date. The Company continues its evaluation of the facts and circumstances available as of May 1, 2019, to assign fair values to assets acquired and liabilities assumed, which could result in further adjustments to the fair values presented below. Purchase price consideration (dollars in thousands): Cash consideration paid $ 833 Total consideration $ 833 Assets acquired at fair value: Premises and equipment $ 78 Premium on loan commitments 209 Other assets 5 Total fair value of assets acquired $ 292 Liabilities assumed at fair value: Total fair value of liabilities assumed $ — Net assets acquired at fair value: $ 292 Amount of goodwill resulting from acquisition $ 541

Investment Securities

Investment Securities	3 Months Ended
	Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Investment Securities	Investment Securities The amortized cost and estimated fair value of securities available for sale along with gross unrealized gains and losses are summarized as follows: (dollars in thousands) March 31, 2020 Amortized Gross Gross Fair Value Securities Available for Sale: State, county & municipal securities $ 6,296 $ 135 $ (21) $ 6,410 Corporate debt securities 2,007 10 — 2,017 Mortgage-backed securities 318,115 7,933 (1,390) 324,658 $ 326,418 $ 8,078 $ (1,411) $ 333,085 (dollars in thousands) December 31, 2019 Amortized Gross Gross Fair Value Securities Available for Sale: State, county & municipal securities $ 5,133 $ 36 $ (54) $ 5,115 Corporate debt securities 2,811 11 (16) 2,806 Mortgage-backed securities 338,930 2,669 (2,188) 339,411 $ 346,874 $ 2,716 $ (2,258) $ 347,332 The amortized cost and fair value of investment securities as of March 31, 2020, by contractual maturity, are shown hereafter. Expected maturities may differ from contractual maturities for certain investments because issuers may have the right to call or prepay obligations with or without call or prepayment penalties. This is often the case with mortgage-backed securities, which are disclosed separately in the table below. Securities Available for Sale (dollars in thousands) Amortized Cost Fair Value Due in one year or less $ 145 $ 147 Due after one year through five years 3,633 3,640 Due after five years through ten years 723 761 Due after ten years 3,802 3,879 $ 8,303 $ 8,427 Mortgage-backed securities 318,115 324,658 $ 326,418 $ 333,085 Proceeds from the sale of investment securities totaled $15.3 million for the three months ended March 31, 2020. The sale of investment securities for the three months ended March 31, 2020 resulted in gross realized gains of $355,000 and losses of $62,000. The Bank did not sell any investment securities during the first three months of 2019. Investment securities having a carrying value approximating $118.1 million and $122.3 million were pledged to secure public deposits and for other purposes as of March 31, 2020 and December 31, 2019, respectively. Information pertaining to securities with gross unrealized losses at March 31, 2020 and December 31, 2019 aggregated by investment category and length of time that individual securities have been in a continuous loss position, follows: Less Than 12 Months 12 Months or Greater Total (dollars in thousands) Fair Gross Fair Gross Fair Gross March 31, 2020 State, county & municipal securities $ 1,352 $ (21) $ — $ — $ 1,352 $ (21) Corporate debt securities — — — — — — Mortgage-backed securities 17,829 (349) 18,403 (1,041) 36,232 (1,390) $ 19,181 $ (370) $ 18,403 $ (1,041) $ 37,584 $ (1,411) December 31, 2019 State, county & municipal securities $ 3,257 $ (54) $ — $ — $ 3,257 $ (54) Corporate debt securities — — 784 (16) 784 (16) Mortgage-backed securities 60,860 (277) 119,110 (1,911) 179,970 (2,188) $ 64,117 $ (331) $ 119,894 $ (1,927) $ 184,011 $ (2,258) Management evaluates securities for other-than-temporary impairment at least on a quarterly basis, and more frequently when economic or market concerns warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer and (3) the intent and ability of the Company to retain its investment in the issuer for a period of time sufficient to allow for any anticipated recovery in fair value. At March 31, 2020, twenty-two securities have unrealized losses. These securities are guaranteed by either the U.S. Government, other governments or U.S. corporations. In analyzing an issuer’s financial condition, management considers whether the securities are issued by the federal government or its agencies, whether downgrades by bond rating agencies have occurred and the results of reviews of the issuer’s financial condition. The unrealized losses are largely due to increases in market interest rates over the yields available at the time the underlying securities were purchased. As management has the ability to hold debt securities until maturity, or for the foreseeable future if classified as available-for-sale, no declines are deemed to be other than temporary.

Allowance for Loan Losses

Allowance for Loan Losses	3 Months Ended
	Mar. 31, 2020
Receivables [Abstract]
Allowance for Loan Losses	Allowance for Loan Losses The following tables detail activity in the allowance for loan losses, segregated by class of loan, for the three months periods ended March 31, 2020 and March 31, 2019. Allocation of a portion of the allowance to one category of loans does not preclude its availability to absorb losses in other loan categories and periodically may result in reallocation within the provision categories. (dollars in thousands) Construction, land and land development Other commercial real estate Residential real estate Commercial, financial & agricultural Consumer and other Total Three months ended March 31, 2020 Beginning Balance $ 215 $ 3,908 $ 980 $ 1,657 $ 103 $ 6,863 Charge-offs — (30) (64) (68) (351) (513) Recoveries 13 5 4 1 55 78 Provision 126 938 283 190 419 1,956 Ending balance 354 4,821 1,203 1,780 226 8,384 Period end amount allocated to Individually evaluated for impairment — 2,077 99 981 — 3,157 Collectively evaluated for impairment 354 2,744 1,092 799 138 5,127 Purchase credit impaired — — 12 — 88 100 Ending Balance 354 4,821 1,203 1,780 226 8,384 Loans Individually evaluated for impairment 66 18,595 2,990 2,355 — 24,006 Collectively evaluated for impairment 133,852 505,764 187,961 114,369 22,559 964,505 Purchase credit impaired 119 125 18 62 191 515 Ending balance $ 134,037 $ 524,484 $ 190,969 $ 116,786 $ 22,750 $ 989,026 (dollars in thousands) Construction, land and land development Other commercial real estate Residential real estate Commercial, financial & agricultural Consumer and other Total Three months ended March 31, 2019 Beginning Balance $ 131 $ 5,251 $ 1,181 $ 618 $ 96 $ 7,277 Charge-offs (29) (119) (629) (97) (70) (944) Recoveries 17 34 49 6 19 125 Provision (99) (104) 348 (61) 47 131 Ending balance 20 5,062 949 466 92 6,589 December 31, 2019 Period end amount allocated to Individually evaluated for impairment — 1,939 137 1,073 — 3,149 Collectively evaluated for impairment 215 1,969 837 584 103 3,708 Purchase credit impaired — — 6 — — 6 Ending Balance 215 3,908 980 1,657 103 6,863 Loans Individually evaluated for impairment 67 18,024 3,471 2,246 — 23,808 Collectively evaluated for impairment 95,965 522,181 191,314 112,077 23,322 944,859 Purchase credit impaired 65 34 11 37 — 147 Ending Balance $ 96,097 $ 540,239 $ 194,796 $ 114,360 $ 23,322 $ 968,814 Management continually evaluates the allowance for loan losses methodology seeking to refine and enhance this process as appropriate, and it is likely that the methodology will continue to evolve over time.

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	Leases A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. On January 1, 2019, the Company adopted ASU No. 2016-02 and all subsequent ASUs that modified this topic (collectively referred to as “Topic 842”). For the Company, Topic 842 primarily affected the accounting treatment for operating lease agreements in which the Company is the lessee. Substantially all of the leases in which the Company is the lessee are comprised of real estate for branches and office space with terms extending through 2027. All of our leases are classified as operating leases, and therefore, were previously not recognized on the Company’s consolidated balance sheet. With the adoption of Topic 842, operating lease arrangements are required to be recognized on the consolidated balance sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. The following table represents the consolidated balance sheet classification of the Company’s ROU assets and liabilities. The Company elected not to include short-term leases (i.e., leases with initial terms of twelve months or less), or equipment leases (deemed immaterial) on the consolidated balance sheet. (dollars in thousands) Classification March 31, 2020 December 31, 2019 Assets Operating lease right-of-use assets Other assets $ 692 $ 572 Liabilities Operating lease liabilities Other liabilities 695 547 The calculated amount of the ROU assets and lease liabilities in the table above are impacted by the length of the lease term and the discount rate used to present value the minimum lease payments. The Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. Regarding the discount rate, Topic 842 requires the use of the rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception, on a collateralized basis, over a similar term. For operating leases existing prior to January 1, 2020, the rate for the remaining lease term as of January 1, 2020 was used. Operating lease cost was $52,000 and $30,000 for the three months ended March 31, 2020 and 2019, respectively. As of March 31, 2020, the weighted average remaining lease term was 4.66 years and the weighted average discount rate was 1.80%. The following table represents the future maturities of the Company’s operating lease liabilities and other lease information. (dollars in thousands) Twelve months ended March 31, Lease Liability 2021 $ 245 2022 157 2023 126 2024 45 2025 45 After March 31, 2025 120 Total lease payments $ 738 Less: interest (43) Present value of lease liabilities $ 695 (dollars in thousands) Supplemental lease information: March 31, 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases (cash payments) $ 50 Operating cash flows from operating leases (lease liability reduction) 42 Operating lease right-of-use assets obtained in exchange for leases entered into during the period 195

Borrowings

Borrowings	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Borrowings	Borrowings The following table presents information regarding the Company’s outstanding borrowings at March 31, 2020 and December 31, 2019: (dollars in thousands) March 31, 2020 December 31, 2019 Federal Home Loan Bank advances $ 36,500 $ 47,000 Other borrowings 14,563 14,563 $ 51,063 $ 61,563 Advances from the Federal Home Loan Bank (“FHLB”) have maturities ranging from 2021 to 2029 and interest rates ranging from 0.52% to 3.51%. As collateral on the outstanding FHLB advances, the Company has provided a blanket lien on its portfolio of qualifying residential first mortgage loans, commercial loans, multifamily loans and HELOC loans. At March 31, 2020, the lendable collateral of those loans pledged is $103.1 million. At March 31, 2020, the Company had remaining credit availability from the FHLB of $341.4 million. The Company may be required to pledge additional qualifying collateral in order to utilize the full amount of the remaining credit line. On May 1, 2019, the Company completed a borrowing arrangement with a correspondent bank for $10.0 million. The term note is secured by the Bank’s stock, expires on May 1, 2024, and bears a fixed interest rate of 4.7%. The proceeds were used for the acquisition of LBC Bancshares, Inc. and its subsidiary, Calumet Bank. As of March 31, 2020, the outstanding balance totaled $9.3 million. On May 1, 2019, the Company completed a revolving credit arrangement with a correspondent bank with a maximum line amount of $10.0 million. This line of credit is secured by the Bank’s stock, expires on May 1, 2021, and bears a variable interest rate of Wall Street Journal Prime minus 0.4%. The Company advanced $5.3 million that was used toward the acquisition of LBC Bancshares, Inc. and its subsidiary, Calumet Bank. As of March 31, 2020, the outstanding balance totaled $5.3 million. The aggregate stated maturities of other borrowed money at March 31, 2020 are as follows: (in thousands) Year Amount 2021 $ 5,313 2022 14,000 2023 3,000 2024 9,250 2025 and After 19,500 $ 51,063 The Company also has available federal funds lines of credit with various financial institutions totaling $55.0 million, none of which were outstanding at March 31, 2020. The Company has the ability to borrow funds from the Federal Reserve Bank (“FRB”) of Atlanta utilizing the discount window. The discount window is an instrument of monetary policy that allows eligible institutions to borrow money from the FRB on a short-term basis to meet temporary liquidity shortages caused by internal or external disruptions. At March 31, 2020, the Company had borrowing capacity available under this arrangement, with no outstanding balances. The Company would be required to pledge certain available-for-sale investment securities as collateral under this agreement. The Company's Trust Preferred Securities are recorded as subordinated debentures on the consolidated balance sheets, but subject to certain limitations, qualify as Tier 1 Capital for regulatory capital purposes. At March 31, 2020 and December 31, 2019, Trust Preferred Securities was $24.2 million. The proceeds from the offerings were used to fund certain acquisitions, pay off holding company debt and inject capital into the bank subsidiary. The Trust preferred securities pay interest quarterly.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic earnings per share is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding during each period. Diluted earnings per share reflects the potential dilution of restricted stock and common stock warrants. Net income available to common stockholders represents net income after preferred stock dividends. The following table presents earnings per share for the three month period ended March 31, 2020 and 2019. (dollars in thousands except per share data) Three Months Ended 2020 2019 Numerator Net income available to common stockholders $ 1,603 $ 2,835 Denominator Weighted average number of common shares Outstanding for basic earnings per common share 9,499 8,440 Weighted-average number of shares outstanding for diluted earnings per common share 9,499 8,440 Earnings per share - basic $ 0.17 $ 0.34 Earnings per share - diluted $ 0.17 $ 0.34

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Credit-Related Financial Instruments. The Company is a party to credit related financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit, standby letters of credit and commercial letters of credit. Such commitments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the consolidated balance sheets. The Company’s exposure to credit loss is represented by the contractual amount of these commitments. The Company follows the same credit policies in making commitments as it does for on-balance sheet instruments. The Company evaluates each customer’s creditworthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary, upon extension of credit, is based on management’s credit evaluation of the borrower. Collateral held varies, but may include cash or cash equivalents, negotiable instruments, real estate, accounts receivable, inventory, oil, gas and mineral interests, property, plant, and equipment. At March 31, 2020 and December 31, 2019 the following financial instruments were outstanding whose contract amounts represent credit risk: Contract Amount (dollars in thousands) March 31, 2020 December 31, 2019 Loan commitments $ 147,433 $ 102,890 Letters of credit 2,626 1,576 Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. The commitments for equity lines of credit may expire without being drawn upon. Therefore, the total commitment amounts do not necessarily represent future cash requirements. The amount of collateral obtained, if it is deemed necessary by the Company, is based on management’s credit evaluation of the customer. Unfunded commitments under commercial lines of credit, revolving credit lines and overdraft protection agreements are commitments for possible future extensions of credit to existing customers. These lines of credit are uncollateralized and usually do not contain a specified maturity date and may not be drawn upon to the total extent to which the Company is committed. Standby and performance letters of credit are conditional lending commitments issued by the Company to guarantee the performance of a customer to a third party. Those letters of credit are primarily issued to support public and private borrowing arrangements. Essentially all letters of credit issued have expiration dates within one year. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loan facilities to customers. Legal Contingencies . In the ordinary course of business, there are various legal proceedings pending against the Company and the Bank. As of March 31, 2020, the aggregate liabilities, if any, arising from such proceedings would not, in the opinion of management, have a material adverse effect on the Company’s consolidated financial position.

Fair Value of Financial Instrum

Fair Value of Financial Instruments and Fair Value Measurements	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments and Fair Value Measurements	Fair Value of Financial Instruments and Fair Value Measurements Generally accepted accounting standards in the U.S. require disclosure of fair value information about financial instruments, whether or not recognized on the face of the balance sheet, for which it is practicable to estimate that value. The assumptions used in the estimation of the fair value of the Company and the Bank’s financial instruments are detailed hereafter. Where quoted prices are not available, fair values are based on estimates using discounted cash flows and other valuation techniques. The use of discounted cash flows can be significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. Generally accepted accounting principles related to Fair Value Measurements define fair value, establish a framework for measuring fair value, establish a three-level valuation hierarchy for disclosure of fair value measurement and enhance disclosure requirements for fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows: • Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. • Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. • Level 3 inputs to the valuation methodology are unobservable and represent the Company’s own assumptions about the assumptions that market participants would use in pricing the assets or liabilities. The following disclosures should not be considered a surrogate of the liquidation value of the Company, but rather a good-faith estimate of the increase or decrease in value of financial instruments held by the Company since purchase, origination or issuance. Cash and short-term investments – For cash, due from banks, bank-owned deposits and federal funds sold, the carrying amount is a reasonable estimate of fair value and is classified as Level 1. Investment securities – Fair values for investment securities are based on quoted market prices where available and classified as Level 1. If quoted market prices are not available, estimated fair values are based on quoted market prices of comparable instruments and classified as Level 2. If a comparable is not available, the investment securities are classified as Level 3. Other investments, at cost – The fair value of Federal Home Loan Bank stock approximates carrying value and is classified as Level 1. If quoted market prices are not available, estimated fair values are based on quoted market prices of comparable instruments and classified as Level 2. Loans held for sale – The fair value of loans held for sale is determined on outstanding commitments from third party investors in the secondary markets and is classified within Level 2 of the valuation hierarchy. Loans – The fair value of fixed rate loans is estimated by discounting the future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings. For variable rate loans, the carrying amount is a reasonable estimate of fair value. Most loans are classified as Level 3. Deposit liabilities – The fair value of demand deposits, savings accounts and certain money market deposits is the amount payable on demand at the reporting date and is classified as Level 1. The fair value of fixed maturity certificates of deposit is estimated by discounting the future cash flows using the rates currently offered for deposits of similar remaining maturities and is classified as Level 2. Subordinated debentures – The fair value of subordinated debentures is estimated by discounting the future cash flows using the current rates at which similar advances would be obtained. Subordinate Debentures are classified as Level 2. Other borrowings – The fair value of other borrowings is calculated by discounting contractual cash flows using an estimated interest rate based on current rates available to the Company for debt of similar remaining maturities and collateral terms. Other borrowings is classified as Level 2 due to their expected maturities. Disclosures of the fair value of financial assets and financial liabilities, including those financial assets and financial liabilities that are not measured and reported at fair value on a recurring basis or non-recurring basis, are required in the financial statements. The carrying amount, estimated fair values, and placement in the fair value hierarchy of the Company’s financial instruments as of March 31, 2020 and December 31, 2019 are as follows: (dollars in thousands) Fair Value Measurements Carrying Estimated Level Level Level March 31, 2020 Assets Cash and short-term investments $ 95,827 $ 95,827 $ 95,827 $ — $ — Investment securities available for sale 333,085 333,085 — 331,068 2,017 Other investments, at cost 3,891 3,891 3,162 729 — Loans held for sale 11,022 11,022 — 11,022 — Loans, net 980,642 1,003,928 — — 1,003,928 Liabilities Deposits 1,293,076 1,293,076 — 1,293,076 — Subordinated debentures 24,229 24,229 — 24,229 — Other borrowings 51,063 48,465 — 48,465 (dollars in thousands) Fair Value Measurements Carrying Estimated Level Level Level December 31, 2019 Assets Cash and short-term investments $ 104,092 $ 104,092 $ 104,192 $ — $ — Investment securities available for sale 347,332 347,332 — 345,310 2,022 Other investments, at cost 4,288 4,288 3,559 729 — Loans held for sale 10,076 10,076 — 10,076 — Loans, net 961,696 938,475 — — 938,475 Liabilities Deposits 1,293,742 1,294,506 — 1,294,506 — Subordinated debentures 24,229 24,229 — 24,229 — Other borrowings 61,563 60,585 — 60,585 — Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument. Because no market exists for a significant portion of the Company’s financial instruments, fair value estimates are based on many judgments. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. Fair value estimates are based on existing on and off-balance sheet financial instruments without attempting to estimate the value of anticipated future business and the value of assets and liabilities that are not considered financial instruments. Significant assets and liabilities that are not considered financial instruments include deferred income taxes and premises and equipment. In addition, the tax ramifications related to the realization of the unrealized gains and losses can have a significant effect on fair value estimates and have not been considered in the estimates. Following is a description of the valuation methodologies used for instruments measured at fair value on a recurring and nonrecurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy: Securities – Where quoted prices are available in an active market, securities are classified within level 1 of the valuation hierarchy. Level 1 inputs include securities that have quoted prices in active markets for identical assets. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, or discounted cash flow. Examples of such instruments, which would generally be classified within level 2 of the valuation hierarchy, include certain collateralized mortgage and debt obligations and certain high-yield debt securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within level 3 of the valuation hierarchy. When measuring fair value, the valuation techniques available under the market approach, income approach and/or cost approach are used. The Company’s evaluations are based on market data and the Company employs combinations of these approaches for its valuation methods depending on the asset class. Impaired Loans – Impaired loans are those loans which the Company has measured impairment generally based on the fair value of the loan’s collateral. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the expected proceeds. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. Other Real Estate – Other real estate owned assets are adjusted to fair value less estimated selling costs upon transfer of the loans to other real estate. Typically, an external, third-party appraisal is performed on the collateral upon transfer into the other real estate account to determine the asset’s fair value. Subsequent adjustments to the collateral’s value may be based upon either updated third-party appraisals or management’s knowledge of the collateral and the current real estate market conditions. Appraised amounts used in determining the asset’s fair value, whether internally or externally prepared, are discounted 10% to account for selling and marketing costs. Adjustments are routinely made in the appraisal process by the appraisers to adjust for differences between the comparable sales and income data available. Such adjustments are typically significant and result in a level 3 classification of the inputs for determining fair value. Because of the high degree of judgment required in estimating the fair value of other real estate assets and because of the relationship between fair value and general economic conditions, we consider the fair value of other real estate assets to be highly sensitive to changes in market conditions. Assets Measured at Fair Value on a Recurring and Nonrecurring Basis – The following table presents the recorded amount of the Company’s assets measured at fair value on a recurring and nonrecurring basis as of March 31, 2020 and December 31, 2019, aggregated by the level in the fair value hierarchy within which those measurements fall. The table below includes only impaired loans with a specific reserve and only other real estate properties with a valuation allowance at March 31, 2020 and December 31, 2019. Those impaired loans and other real estate properties are shown net of the related specific reserves and valuation allowances. (dollars in thousands) Fair Value Measurements at Reporting Date Using March 31, 2020 Total Fair Value Quoted Prices in Significant Other Significant Recurring Securities Available for Sale State, county & municipal securities $ 6,410 $ — $ 6,410 $ — Corporate Debt securities 2,017 — — 2,017 Mortgage-backed securities 324,658 — 324,658 — Total available for sale securities $ 333,085 $ — $ 331,068 $ 2,017 Nonrecurring Collateral Dependent Impaired Loans 4,509 — — 4,509 Other Real Estate 847 — — 847 Total nonrecurring assets $ 5,356 $ — $ — $ 5,356 (dollars in thousands) Fair Value Measurements at Reporting Date Using December 31, 2019 Total Fair Quoted Prices in Significant Other Significant Recurring Securities Available for Sale State, county & municipal securities $ 5,115 $ — $ 5,115 $ — Corporate Debt securities 2,806 — 784 2,022 Mortgage-backed securities 339,411 — 339,411 — Total available for sale securities $ 347,332 $ — $ 345,310 $ 2,022 Nonrecurring Collateral Dependent Impaired Loans 5,985 — — 5,985 Other Real Estate 1,320 — — 1,320 Total nonrecurring assets $ 7,305 $ — $ — $ 7,305 Fair Value Measurements Using Significant Unobservable Inputs (Level 3) The following table presents quantitative information about the significant unobservable inputs used in the fair value measurements for assets in level 3 of the fair value hierarchy measured on a nonrecurring basis at March 31, 2020 and December 31, 2019. This table is comprised primarily of collateral dependent impaired loans and other real estate: (dollars in thousands) March 31, 2020 Valuation Unobservable Range Collateral Dependent Impaired Loans $ 4,509 Appraised Value Discounts to reflect current market conditions, ultimate collectability, and estimated costs to sell 10 % 50 % Other Real Estate 847 Appraised Value/Comparable Sales Discounts to reflect current market conditions and estimated costs to sell — % 20 % (dollars in thousands) December 31, 2019 Valuation Unobservable Range Collateral Dependent Impaired Loans $ 5,985 Appraised Value Discounts to reflect current market conditions, ultimate collectability, and estimated costs to sell — % 20 % Other Real Estate 1,320 Appraised Value/Comparable Sales Discounts to reflect current market conditions and estimated costs to sell — % 20 % The table below presents a reconciliation and statement of income classification of gains and losses for all assets measured at fair value on a recurring basis using significant unobservable inputs (level 3) for the three months ended March 31, 2020 and 2019. (dollars in thousands) Available for Sale Securities March 31, 2020 March 31, 2019 Balance, Beginning $ 2,022 $ 4,277 Transfers out of Level 3 — — Sales — — Paydowns (5) (390) Realized Loss on Sale of Security — — Unrealized gains included in Other Comprehensive Income — 10 Balance, Ending $ 2,017 $ 3,897 The Company’s policy is to recognize transfers in and transfers out of levels 1, 2 and 3 as of the end of a reporting period. There were no transfers of securities between levels for the three months ended March 31, 2020 and one security totaling $2,009 transferred from level 3 to level 2 for the twelve months ended December 31, 2019. The following table presents quantitative information about recurring level 3 fair value measurements as of March 31, 2020. (dollars in thousands) March 31, 2020 Fair Value Valuation Techniques Unobservable Range Corporate debt securities $ 2,017 Discounted Cash Flow Discount Rate or Yield N/A* December 31, 2019 Corporate debt securities $ 2,022 Discounted Cash Flow Discount Rate or Yield N/A* * The Company relies on a third-party pricing service to value its securities. The details of the unobservable inputs and other adjustments used by the third-party pricing service were not readily available to the Company.

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Segment Information	Segment Information The Company’s operating segments include banking, mortgage banking and small business specialty lending division. The reportable segments are determined by the products and services offered, and internal reporting. The Bank segment derives its revenues from the delivery of full-service financial services, including retail and commercial banking services and deposit accounts. The Mortgage Banking segment derives its revenues from the origination and sales of residential mortgage loans held for sale. The Small Business Specialty Lending Division segment derives its revenue from the origination, sales and servicing of Small Business Administration loans and other government guaranteed loans. Segment performance is evaluated using net interest income and noninterest income. Income taxes are allocated based on income before income taxes, and indirect expenses (includes management fees) are allocated based on various internal factors for each segment. Transactions among segments are made at fair value. Information reported internally for performance assessment follows. The following tables present information reported internally for performance assessment for the three months periods ended March 31, 2020 and 2019: (dollars in thousands) Bank Mortgage Small Totals Three Months Ended March 31, 2020 Net Interest Income $ 12,656 $ 34 $ 14 $ 12,704 Provision for Loan Losses 1,956 — — 1,956 Noninterest Income 3,049 1,253 259 4,561 Noninterest Expenses 11,667 1,195 516 13,378 Income Taxes 368 11 (51) 328 Segment Profit (Loss) $ 1,714 $ 81 $ (192) $ 1,603 Segments Assets at March 31, 2020 $ 1,497,788 $ 11,082 $ 1,178 $ 1,510,048 (dollars in thousands) Bank Mortgage Small Totals Three Months Ended March 31, 2019 Net Interest Income $ 10,357 $ — $ — $ 10,357 Provision for Loan Losses 131 — — 131 Noninterest Income 2,334 — — 2,334 Noninterest Expenses 9,026 — — 9,026 Income Taxes 699 — — 699 Segment Profit $ 2,835 $ — $ — $ 2,835 Segments Assets at March 31, 2019 $ 1,503,284 $ 11,624 $ 405 $ 1,515,313

Regulatory Capital Matters

Regulatory Capital Matters	3 Months Ended
	Mar. 31, 2020
Banking and Thrift [Abstract]
Regulatory Capital Matters	Regulatory Capital Matters The amount of dividends payable to the parent company from the subsidiary bank is limited by various banking regulatory agencies. Upon approval by regulatory authorities, the Bank may pay cash dividends to the parent company in excess of regulatory limitations. The Company is subject to various regulatory capital requirements administered by federal banking agencies. Failure to meet minimum capital requirements can initiate certain mandatory and, possibly, additional discretionary actions by regulators that, if undertaken, could have a direct material effect on the Company’s consolidated financial statements. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Company must meet specific capital guidelines that involve quantitative measures of the Company’s assets, liabilities and certain off-balance sheet items as calculated under regulatory accounting practices. The Company’s capital amounts and classifications are also subject to qualitative judgments by the regulators about components, risk weightings and other factors. Quantitative measures established by regulation to ensure capital adequacy require the Company to maintain minimum amounts and ratios of total and Tier 1 capital to risk-weighted assets, and of Tier 1 capital to average assets. As of March 31, 2020, the interim final Basel III rules (“Basel III”) require the Company to also maintain minimum amounts and ratios of common equity Tier 1 capital to risk-weighted assets. These amounts and ratios as defined in regulations are presented hereafter. Management believes, as of March 31, 2020, the Company meets all capital adequacy requirements to which it is subject under the regulatory framework for prompt corrective action. In the opinion of management, there are no events or conditions since prior notification of capital adequacy from the regulators that have changed the institution’s category. The Basel III rules also require the implementation of a new capital conservation buffer comprised of common equity Tier 1 capital. The capital conservation buffer was phased in beginning January 1, 2016 at 0.625% of risk-weighted assets and increase each subsequent year by 0.625% until reaching its final level of 2.5% on January 1, 2019. The Board of Governors of the Federal Reserve raised the threshold for determining applicable of the Small Bank Holding Company and Savings and Loan Company Policy Statement in August 2018 from $1 billion to $3 billion in consolidated total assets to provide regulatory burden relief, therefore, the Company is no longer subject to the minimum capital requirements. The following table summarizes regulatory capital information as of March 31, 2020 and December 31, 2019 on a consolidated basis and for the subsidiary, as defined. Regulatory capital ratios for March 31, 2020 and December 31, 2019 were calculated in accordance with the Basel III rules. (dollars in thousands) Actual For Capital To Be Well Amount Ratio Amount Ratio Amount Ratio As of March 31, 2020 Total Capital to Risk-Weighted Assets Consolidated $ 138,789 13.47 % $ 82,429 8.00 % N/A N/A Colony Bank 148,961 13.98 85,242 8.00 $ 106,553 10.00 % Tier I Capital to Risk-Weighted Assets Consolidated 132,189 12.68 62,550 6.00 N/A N/A Colony Bank 140,577 13.19 63,947 6.00 85,263 8.00 Common Equity Tier I Capital to Risk-Weighted Assets Consolidated 108,689 10.47 46,714 4.50 N/A N/A Colony Bank 140,577 13.19 47,960 4.50 69,276 6.50 Tier I Capital to Average Assets Consolidated 132,189 9.06 58,362 4.00 N/A N/A Colony Bank 140,577 9.46 59,441 4.00 74,301 5.00 (dollars in thousands) Actual For Capital To Be Well Amount Ratio Amount Ratio Amount Ratio As of December 31, 2019 Total Capital to Risk-Weighted Assets Consolidated $ 140,973 13.17 % $ 85,661 8.00 % N/A N/A Colony Bank 151,444 14.19 85,407 8.00 $ 106,758 10.00 % Tier I Capital to Risk-Weighted Assets Consolidated 134,110 12.52 64,246 6.00 N/A N/A Colony Bank 144,581 13.54 64,055 6.00 8,547 8.00 Common Equity Tier I Capital to Risk-Weighted Assets Consolidated 110,610 10.33 48,185 4.50 N/A N/A Colony Bank 144,581 13.54 48,041 4.50 69,393 6.50 Tier I Capital to Average Assets Consolidated 134,110 8.92 60,141 4.00 N/A N/A Colony Bank 144,581 9.77 59,977 4.00 74,972 5.00

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Dividend On April 22, 2020, the Board of Directors declared a cash dividend of $0.10 per share to shareholders of record on May 8, 2020, payable on May 22, 2020. COVID-19 On March 11, 2020, the World Health Organization declared COVID-19, the disease caused by the novel coronavirus, a pandemic as a result of the global spread of the coronavirus illness. The COVID-19 pandemic has adversely affected, and may continue to adversely affect economic activity globally, nationally and locally. In response to the outbreak, federal and state authorities in the United States introduced various measures to try to limit or slow the spread of the virus, including travel restrictions, nonessential business closures, stay-at-home orders, and strict social distancing. The full impact of the COVID-19 pandemic is unknown and rapidly evolving. It has caused substantial disruption in international and U.S. economies, markets, and employment. The COVID-19 pandemic may have a significant adverse impact on certain industries the Company serves, including restaurants and food services, hotels, retail and energy. On March 27, 2020, the CARES Act, a stimulus package intended to provide relief to businesses and consumers in the United States struggling as a result of the pandemic, was signed into law. Section 4013 of the CARES Act also addressed COVID-19-related modifications and specified that COVID-19-related modifications executed between March 1, 2020 and the earlier of (i) 60 days after the date of termination of the national emergency declared by the President and (ii) December 31, 2020, on loans that were current as of December 31, 2019 are not TDRs. Additionally, under guidance from the federal banking agencies, other short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief are not TDRs under ASC Subtopic 310-40. These modifications include short-term (e.g., up to six months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or delays in payment that are insignificant. Borrowers considered current are those that are less than 30 days past due on their contractual payments at the time a modification program is implemented.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Presentation	Presentation Colony Bankcorp, Inc. (the “Company”) is a bank holding company located in Fitzgerald, Georgia. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Colony Bank, Fitzgerald, Georgia (the “Bank”). The “Company” or “our,” as used herein, includes Colony Bank. In July 2019, a new subsidiary of the Company was incorporated under the name Colony Risk Management, Inc. Colony Risk Management, Inc. is a subsidiary of the Company and is located in Las Vegas, Nevada. It is a captive insurance subsidiary which insures various liability and property damage policies for the Company and its related subsidiaries. Colony Risk Management is regulated by the State of Nevada Division of Insurance. All dollars in notes to consolidated financial statements are rounded to the nearest thousands, except for per share amounts. The consolidated financial statements in this report are unaudited, except for the December 31, 2019 consolidated balance sheet. All adjustments consisting of normal recurring accruals which are, in the opinion of management, necessary for fair presentation of the interim consolidated financial statements, have been included and fairly and accurately present the financial position, results of operations and cash flows of the Company. All significant intercompany accounts have been eliminated in consolidation. The accounting and reporting policies of the Company conform to generally accepted accounting principles and practices utilized in the commercial banking industry for interim financial information and Regulation S-X. Accordingly, they do not include all of the information or notes required for complete financial statements. The results of operations for the three months ended March 31, 2020 are not necessarily indicative of the results which may be expected for the year ending December 31, 2020. These statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2019 in the Company's 2019 10-K. The Company’s significant accounting policies are described in Note 1 of the Notes to Consolidated Financial Statements for the year ended December 31, 2019, which are included in the Company’s 2019 Form 10-K. For interim reporting purposes, the Company follows the same basic accounting policies and considers each interim period as an integral part of an annual period.
Nature of Operations	Nature of Operations The Bank provides a full range of retail, commercial and mortgage banking services for consumers and small- to medium-size businesses located primarily in central, south and coastal Georgia. The Bank is headquartered in Fitzgerald, Georgia with banking and mortgage offices in Albany, Ashburn, Athens, Broxton, Centerville, Columbus, Cordele, Douglas, Eastman, Fitzgerald, LaGrange, Leesburg, Macon, Moultrie, Quitman, Rochelle, Savannah, Soperton, Sylvester, Statesboro, Thomaston, Tifton, Valdosta and Warner Robins. Lending and investing activities are funded primarily by deposits gathered through its retail banking office network.
Use of Estimates	Use of Estimates In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet date and revenues and expenses for the period. Actual results could differ significantly from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, the valuation of real estate acquired in connection with foreclosures or in satisfaction of loans and fair value of assets acquired and liabilities assumed in a business combination.
Reclassifications	Reclassifications In certain instances, amounts reported in prior years’ consolidated financial statements have been reclassified to conform to statement presentations selected for 2020. Such reclassifications have not materially affected previously reported stockholders’ equity or net income.
Concentrations of Credit Risk	Concentrations of Credit Risk Concentrations of credit risk can exist in relation to individual borrowers or groups of borrowers, certain types of collateral, certain types of industries, or certain geographic regions. The Company has a concentration in real estate loans as well as a geographic concentration that could pose an adverse credit risk. At March 31, 2020, approximately 86% of the Company’s loan portfolio was concentrated in loans secured by real estate. A substantial portion of borrowers’ ability to honor their contractual obligations is dependent upon the viability of the real estate economic sector. Management continues to monitor these concentrations and has considered these concentrations in its allowance for loan loss analysis. Concentrations of Credit Risk (Continued) The success of the Company is dependent, to a certain extent, upon the economic conditions in the geographic markets it serves. Adverse changes in the economic conditions in these geographic markets would likely have a material adverse effect on the Company’s results of operations and financial condition. The operating results of the Company depend primarily on its net interest income. Accordingly, operations are subject to risks and uncertainties surrounding the exposure to changes in the interest rate environment. At times, the Company may have cash and cash equivalents at financial institutions in excess of federal deposit insurance limits. The Company places its cash and cash equivalents with high credit quality financial institutions whose credit ratings are monitored by management to minimize credit risk.
Changes in Accounting Principles and effects of New Accounting Pronouncements	Changes in Accounting Principles and Effects of New Accounting Pronouncements ASU 2016-13, Financial Instruments – Credit Losses (Topic 326). This ASU sets forth a “current expected credit loss” (CECL) model which requires the Company to measure all expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable supported forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost and applies to some off-balance sheet credit exposures. This ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. On October 16, 2019, FASB voted to extend the delay of the effective date of this ASU for smaller reporting companies, such as the Company, until fiscal years beginning after December 15, 2022. The Company is currently assessing the impact of the adoption of this ASU on its consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This update removes several exceptions related to intraperiod tax allocation when there is a loss from continuing operations and income from other items, foreign subsidiaries becoming equity method investments and vice versa, and calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. The guidance also amends requirements related to franchise tax that is partially based on income, a step up in the tax basis of goodwill, allocation of consolidated tax expense to a legal entity not subject to tax in its separate financial statements, the effects of enacted changes in tax laws and other minor codification improvements regarding employee stock ownership plans and investments in qualified affordable housing projects. For public entities, this guidance is effective for fiscal years beginning after December 15, 2020. The Company does not expect the new guidance to have a material impact on the consolidated financial statements. In January 2020, the FASB issued ASU No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is effective for fiscal years beginning after December 15, 2020. The Company does not expect the new guidance to have a material impact on the consolidated financial statements. In March 2020, the FAS issued ASU No. 2020-04 "Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting" ("ASU 2020-04"). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of ) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not believe this standard will have a material impact on its consolidated financial statements. Operating, Accounting and Reporting Considerations Related to COVID-19 The COVID-19 pandemic has negatively impacted the global economy, including the Company’s primary metropolitan markets. In response to this crisis, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was passed by Congress and signed into law on March 27, 2020. The CARES Act provides an estimated $2.2 trillion to fight the COVID-19 pandemic and stimulate the economy by supporting individuals and businesses through loans, grants, tax changes, and other types of relief. Some of the provisions applicable to the Company include, but are not limited to: • Accounting for Loan Modifications - The CARES Act provides that financial institutions may elect to suspend (1) the requirements under GAAP for certain loan modifications that would otherwise by categorized as a troubled debt restructure (“TDR”) and (2) any determination that such loan modifications would be considered a TDR, including the related impairment for accounting purposes. • Pay Protection Program - The CARES Act established the Paycheck Protection Program (“PPP”), an expansion of the Small Business Administration’s 7(a) loan program and the Economic Injury Disaster Loan Program (“EIDL”), administered directly by the SBA. Also in response to the COVID-19 pandemic, the Board of Governors of the Federal Reserve System (“FRB”), the Federal Deposit Insurance Corporation (“FDIC”), the National Credit Union Administration (“NCUA”), the Office of the Comptroller of the Currency (“OCC”), and the Consumer Financial Protection Bureau (“CFPB”), in consultation with the state financial regulators (collectively, the “agencies”) issued a joint interagency statement (issued March 22, 2020; revised statement issued April 7, 2020). Some of the provisions applicable to the Company include, but are not limited to: • Accounting for Loan Modifications - Loan modifications that do not meet the conditions of the CARES Act may still qualify as a modification that does not need to be accounted for as a TDR. The agencies confirmed with FASB staff that short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief are not TDRs. This includes short-term (e.g., three months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or insignificant delays in payment, as long as such modifications are (1) related to COVID-19; (2) executed on a loan that was not more than 30 days past due as of December 31, 2019; and (3) executed between March 1, 2020, and the earlier of (a) 60 days after the date of termination of the national emergency declaration or (b) December 31, 2020. • Past Due Reporting - With regard to loans not otherwise reportable as past due, financial institutions are not expected to designate loans with deferrals granted due to COVID-19 as past due because of the deferral. A loan’s payment date is governed by the due date stipulated in the legal agreement. If a financial institution agrees to a payment deferral, these loans would not be considered past due reporting during the period of the deferral. • Nonaccrual Status and Charge-offs - During short-term COVID-19 modifications, these loans generally should not be reported as nonaccrual or as classified.

Business Acquisitions (Tables)

Business Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	Purchase price consideration (dollars in thousands): Shares of CBAN common stock issued to LBC shareholders as of May 1, 2019 1,053,875 Market price of CBAN common stock on May 1, 2019 $ 17.75 Estimated fair value of CBAN common stock issued 18,706 Cash consideration paid 15,315 Total consideration $ 34,021 Assets acquired at fair value: Cash and cash equivalents $ 15,678 Investments securities available for sale 49,172 Investments securities held to maturity 1,766 Restricted investments 479 Loans 130,568 Premises and equipment 3,009 Core deposit intangible 3,100 Other real estate 243 Prepaid and other assets 6,143 Total fair value of assets acquired $ 210,158 Liabilities assumed at fair value: Deposits $ (189,896) FHLB advances (1,000) Payables and other liabilities (975) Total fair value of liabilities assumed $ (191,871) Net assets acquired at fair value: $ 18,287 Amount of goodwill resulting from acquisition $ 15,734 Purchase price consideration (dollars in thousands): Cash consideration paid $ 833 Total consideration $ 833 Assets acquired at fair value: Premises and equipment $ 78 Premium on loan commitments 209 Other assets 5 Total fair value of assets acquired $ 292 Liabilities assumed at fair value: Total fair value of liabilities assumed $ — Net assets acquired at fair value: $ 292 Amount of goodwill resulting from acquisition $ 541
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities Acquired During Period	(dollars in thousands) Contractually required principal and interest $ 695 Non-accretable difference (519) Cash Flows expected to be collected 176 Accretable yield — Total purchased credit-impaired loans acquired $ 176
Schedule of Business Acquisitions by Acquisition, Acquired Loan Data	The following table presents the acquired loan data for the LBC acquisition. (dollars in thousands) Fair Value of Gross Contractual Estimate at Acquired receivables subject to ASC 310-30 $ 176 $ 695 $ 519 Acquired receivables not subject to ASC 310-30 130,392 132,381 —

Investment Securities (Tables)

Investment Securities (Tables)	3 Months Ended
	Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	The amortized cost and estimated fair value of securities available for sale along with gross unrealized gains and losses are summarized as follows: (dollars in thousands) March 31, 2020 Amortized Gross Gross Fair Value Securities Available for Sale: State, county & municipal securities $ 6,296 $ 135 $ (21) $ 6,410 Corporate debt securities 2,007 10 — 2,017 Mortgage-backed securities 318,115 7,933 (1,390) 324,658 $ 326,418 $ 8,078 $ (1,411) $ 333,085 (dollars in thousands) December 31, 2019 Amortized Gross Gross Fair Value Securities Available for Sale: State, county & municipal securities $ 5,133 $ 36 $ (54) $ 5,115 Corporate debt securities 2,811 11 (16) 2,806 Mortgage-backed securities 338,930 2,669 (2,188) 339,411 $ 346,874 $ 2,716 $ (2,258) $ 347,332
Investments Classified by Contractual Maturity Date	This is often the case with mortgage-backed securities, which are disclosed separately in the table below. Securities Available for Sale (dollars in thousands) Amortized Cost Fair Value Due in one year or less $ 145 $ 147 Due after one year through five years 3,633 3,640 Due after five years through ten years 723 761 Due after ten years 3,802 3,879 $ 8,303 $ 8,427 Mortgage-backed securities 318,115 324,658 $ 326,418 $ 333,085
Schedule of Unrealized Loss on Investments	Information pertaining to securities with gross unrealized losses at March 31, 2020 and December 31, 2019 aggregated by investment category and length of time that individual securities have been in a continuous loss position, follows: Less Than 12 Months 12 Months or Greater Total (dollars in thousands) Fair Gross Fair Gross Fair Gross March 31, 2020 State, county & municipal securities $ 1,352 $ (21) $ — $ — $ 1,352 $ (21) Corporate debt securities — — — — — — Mortgage-backed securities 17,829 (349) 18,403 (1,041) 36,232 (1,390) $ 19,181 $ (370) $ 18,403 $ (1,041) $ 37,584 $ (1,411) December 31, 2019 State, county & municipal securities $ 3,257 $ (54) $ — $ — $ 3,257 $ (54) Corporate debt securities — — 784 (16) 784 (16) Mortgage-backed securities 60,860 (277) 119,110 (1,911) 179,970 (2,188) $ 64,117 $ (331) $ 119,894 $ (1,927) $ 184,011 $ (2,258)

Loans (Tables)

Loans (Tables)	3 Months Ended
	Mar. 31, 2020
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable	The following table presents the composition of loans segregated by legacy and purchased loans and by class of loans, as of March 31, 2020 and December 31, 2019. Purchased loans are defined as loans that were acquired in bank acquisitions. March 31, 2020 (dollars in thousands) Legacy Loans Purchased Loans Total Construction, land and land development $ 86,268 $ 47,769 $ 134,037 Other commercial real estate 466,761 57,723 524,484 Total commercial real estate 553,029 105,492 658,521 Residential real estate 169,199 21,770 190,969 Commercial, financial, & agricultural 99,121 17,665 116,786 Consumer and other 19,303 3,447 22,750 Total Loans $ 840,652 $ 148,374 $ 989,026 December 31, 2019 (dollars in thousands) Legacy Loans Purchased Loans Total Construction, land and land development $ 83,036 $ 13,061 $ 96,097 Other commercial real estate 481,943 58,296 540,239 Total commercial real estate 564,979 71,357 636,336 Residential real estate 171,341 23,455 194,796 Commercial, financial, & agricultural 91,535 22,825 114,360 Consumer and other 19,245 4,077 23,322 Total Loans $ 847,100 $ 121,714 $ 968,814
Financing Receivable Credit Quality Indicators	The following table presents the loan portfolio, excluding purchased loans, by credit quality indicator (risk grade) as of March 31, 2020 and December 31, 2019. Those loans with a risk grade of 1, 2, 3 or 4 have been combined in the pass column for presentation purposes. For the period ending March 31, 2020 and December 31, 2019, the Company did not have any loans classified as “doubtful” or a “loss”. (dollars in thousands) Pass Special Mention Substandard Total Loans March 31, 2020 Construction, land and land development $ 85,515 $ 431 $ 322 $ 86,268 Other commercial real estate 445,603 11,123 10,035 466,761 Total commercial real estate 531,118 11,554 10,357 553,029 Residential real estate 157,935 4,496 6,768 169,199 Commercial, financial, & agricultural 94,465 1,713 2,943 99,121 Consumer and other 18,927 178 198 19,303 Total Loans $ 802,445 $ 17,941 $ 20,266 $ 840,652 (dollars in thousands) December 31, 2019 Construction, land and land development $ 82,322 $ 445 $ 269 $ 83,036 Other commercial real estate 459,064 13,438 9,441 481,943 Total commercial real estate 541,386 13,883 9,710 564,979 Residential real estate 159,194 4,632 7,515 171,341 Commercial, financial, & agricultural 86,558 1,973 3,004 91,535 Consumer and other 18,883 148 214 19,245 Total Loans $ 806,021 $ 34,519 $ 20,443 $ 847,100 The following table presents the purchased loan portfolio by credit quality indicator (risk grade) as of March 31, 2020 and December 31, 2019. Those loans with a risk grade of 1, 2, 3 or 4 have been combined in the pass column for presentation purposes. For the period ending March 31, 2020, the Company did not have any loans classified as “doubtful” or a “loss”. (dollars in thousands) Pass Special Mention Substandard Total Loans March 31, 2020 Construction, land and land development $ 45,953 $ 1,698 $ 118 $ 47,769 Other commercial real estate 54,900 579 2,244 57,723 Total commercial real estate 100,853 2,277 2,362 105,492 Residential real estate 21,348 307 115 21,770 Commercial, financial, & agricultural 14,525 2,981 159 17,665 Consumer and other 3,256 — 191 3,447 Total Loans $ 139,982 $ 5,565 $ 2,827 $ 148,374 December 31, 2019 Construction, land and land development $ 12,996 $ — $ 65 $ 13,061 Other commercial real estate 57,881 381 34 58,296 Total commercial real estate 70,877 381 99 71,357 Residential real estate 23,097 249 109 23,455 Commercial, financial, & agricultural 19,443 2,949 433 22,825 Consumer and other 4,077 — — 4,077 Total Loans $ 117,494 $ 3,579 $ 641 $ 121,714
Financing Receivable, Past Due	The following table represents an age analysis of past due loans and nonaccrual loans for legacy loans, segregated by class of loans, excluding purchased loans as of March 31, 2020 and December 31, 2019: Accruing Loans (dollars in thousands) 30-89 Days 90 Days Total Accruing Nonaccrual Current Loans Total Loans March 31, 2020 Construction, land and land development $ 293 $ — $ 293 $ 81 $ 85,894 $ 86,268 Other commercial real estate 1,390 — 1,390 3,805 461,566 466,761 Total commercial real estate 1,683 — 1,683 3,886 547,460 553,029 Residential real estate 1,635 — 1,635 3,336 164,228 169,199 Commercial, financial, & agricultural 531 — 531 2,779 95,811 99,121 Consumer and other 113 — 113 129 19,061 19,303 Total Loans $ 3,962 $ — $ 3,962 $ 10,130 $ 826,560 $ 840,652 December 31, 2019 Construction, land and land development $ 50 $ — $ 50 $ 32 $ 82,954 $ 83,036 Other commercial real estate 335 — 335 3,738 477,870 481,943 Total commercial real estate 385 — 385 3,770 560,824 564,979 Residential real estate 1,296 — 1,296 3,643 166,402 171,341 Commercial, financial, & agricultural 212 — 212 1,628 89,695 91,535 Consumer and other 21 — 21 138 19,086 19,245 Total Loans $ 1,914 $ — $ 1,914 $ 9,179 $ 836,007 $ 847,100 The following table represents an age analysis of past due loans and nonaccrual loans, segregated by class of loans, for purchased loans as of March 31, 2020 and December 31, 2019: Accruing Loans (dollars in thousands) 30-89 Days 90 Days Total Accruing Nonaccrual Current Loans Total Loans March 31, 2020 Construction, land and land development $ 679 $ — $ 679 $ — $ 47,090 $ 47,769 Other commercial real estate — — — — 57,723 57,723 Total commercial real estate 679 — 679 — 104,813 105,492 Residential real estate — — — — 21,770 21,770 Commercial, financial, & agricultural — — — — 17,665 17,665 Consumer and other 4 — 4 — 3,443 3,447 Total Loans $ 683 $ — $ 683 $ — $ 147,691 $ 148,374 December 31, 2019 Construction, land and land development $ — $ — $ — $ — $ 13,061 $ 13,061 Other commercial real estate 83 — 83 — 58,213 58,296 Total commercial real estate 83 — 83 — 71,274 71,357 Residential real estate 57 — 57 — 23,398 23,455 Commercial, financial, & agricultural 553 — 553 — 22,272 22,825 Consumer and other 8 — 8 — 4,069 4,077 Total Loans $ 701 $ — $ 701 $ — $ 121,013 $ 121,714
Impaired Financing Receivables	The following table details impaired loan data, including purchased credit impaired loans, as of March 31, 2020. (dollars in thousands) March 31, 2020 Unpaid Impaired Related Average With No Related Allowance Recorded Construction, land and land development $ 66 $ 66 $ — $ 67 Commercial real estate 13,124 12,259 — 12,357 Residential real estate 2,477 2,465 — 2,586 Commercial, financial & agriculture 381 381 — 319 Consumer & other — — — — 16,048 15,171 — 15,329 With An Allowance Recorded Construction, land and land development — — — — Commercial real estate 6,336 6,336 2,077 6,358 Residential real estate 525 525 99 641 Commercial, financial & agriculture 1,974 1,974 981 2,082 Consumer & other — — — — 8,835 8,835 3,157 9,081 Purchased Credit Impaired Loans Construction, land and land development 119 119 — 92 Commercial real estate 125 125 — 79 Residential real estate 18 18 12 15 Commercial, financial & agriculture 62 62 — 49 Consumer & other 191 191 88 95 515 515 100 330 Total Construction, land and land development 185 185 — 159 Commercial real estate 19,585 18,720 2,077 18,794 Residential real estate 3,020 3,008 111 3,242 Commercial, financial & agriculture 2,417 2,417 981 2,450 Consumer & other 191 191 88 95 $ 25,398 $ 24,521 $ 3,257 $ 24,740 The following table details impaired loan data as of December 31, 2019. (dollars in thousands) December 31, 2019 Unpaid Impaired Related Average With No Related Allowance Recorded Construction, land and land development $ 67 $ 67 $ — $ 168 Commercial real estate 12,455 11,639 — 13,924 Residential real estate 2,706 2,711 — 3,693 Commercial, financial & agriculture 257 257 910 Consumer & other — — — 123 15,485 14,674 — 18,818 With An Allowance Recorded Construction, land and land development — — — 80 Commercial real estate 6,379 6,385 1,939 3,898 Residential real estate 757 760 137 367 Commercial, financial & agriculture 2,189 1,989 1,073 722 Consumer & other — — — — 9,325 9,134 3,149 5,067 Purchased Credit Impaired Loans Construction, land and land development 65 65 — 80 Commercial real estate 34 34 — 35 Residential real estate 11 11 6 24 Commercial, financial & agriculture 37 37 — 47 Consumer & other — — — — 147 147 6 186 Total Construction, land and land development 132 132 — 328 Commercial real estate 18,868 18,058 1,939 17,857 Residential real estate 3,474 3,482 143 4,084 Commercial, financial & agriculture 2,483 2,283 1,073 1,679 Consumer & other — — — 123 24,957 23,955 3,155 24,071 Interest income recorded on impaired loans during the three months ended March 31, 2020 and 2019 was $50,000, and $43,000 reflects interest income recorded on nonaccrual loans prior to them being placed on nonaccrual status and interest income recorded on TDRs.

Allowance for Loan Losses (Tabl

Allowance for Loan Losses (Tables)	3 Months Ended
	Mar. 31, 2020
Receivables [Abstract]
Financing Receivable, Allowance for Credit Loss	The following tables detail activity in the allowance for loan losses, segregated by class of loan, for the three months periods ended March 31, 2020 and March 31, 2019. Allocation of a portion of the allowance to one category of loans does not preclude its availability to absorb losses in other loan categories and periodically may result in reallocation within the provision categories. (dollars in thousands) Construction, land and land development Other commercial real estate Residential real estate Commercial, financial & agricultural Consumer and other Total Three months ended March 31, 2020 Beginning Balance $ 215 $ 3,908 $ 980 $ 1,657 $ 103 $ 6,863 Charge-offs — (30) (64) (68) (351) (513) Recoveries 13 5 4 1 55 78 Provision 126 938 283 190 419 1,956 Ending balance 354 4,821 1,203 1,780 226 8,384 Period end amount allocated to Individually evaluated for impairment — 2,077 99 981 — 3,157 Collectively evaluated for impairment 354 2,744 1,092 799 138 5,127 Purchase credit impaired — — 12 — 88 100 Ending Balance 354 4,821 1,203 1,780 226 8,384 Loans Individually evaluated for impairment 66 18,595 2,990 2,355 — 24,006 Collectively evaluated for impairment 133,852 505,764 187,961 114,369 22,559 964,505 Purchase credit impaired 119 125 18 62 191 515 Ending balance $ 134,037 $ 524,484 $ 190,969 $ 116,786 $ 22,750 $ 989,026 (dollars in thousands) Construction, land and land development Other commercial real estate Residential real estate Commercial, financial & agricultural Consumer and other Total Three months ended March 31, 2019 Beginning Balance $ 131 $ 5,251 $ 1,181 $ 618 $ 96 $ 7,277 Charge-offs (29) (119) (629) (97) (70) (944) Recoveries 17 34 49 6 19 125 Provision (99) (104) 348 (61) 47 131 Ending balance 20 5,062 949 466 92 6,589 December 31, 2019 Period end amount allocated to Individually evaluated for impairment — 1,939 137 1,073 — 3,149 Collectively evaluated for impairment 215 1,969 837 584 103 3,708 Purchase credit impaired — — 6 — — 6 Ending Balance 215 3,908 980 1,657 103 6,863 Loans Individually evaluated for impairment 67 18,024 3,471 2,246 — 23,808 Collectively evaluated for impairment 95,965 522,181 191,314 112,077 23,322 944,859 Purchase credit impaired 65 34 11 37 — 147 Ending Balance $ 96,097 $ 540,239 $ 194,796 $ 114,360 $ 23,322 $ 968,814

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Balance Sheet Classification of Operating Lease Right-of-use Assets and Lease Liabilities	The following table represents the consolidated balance sheet classification of the Company’s ROU assets and liabilities. The Company elected not to include short-term leases (i.e., leases with initial terms of twelve months or less), or equipment leases (deemed immaterial) on the consolidated balance sheet. (dollars in thousands) Classification March 31, 2020 December 31, 2019 Assets Operating lease right-of-use assets Other assets $ 692 $ 572 Liabilities Operating lease liabilities Other liabilities 695 547
Lessee, Operating Lease, Liability, Maturity	The following table represents the future maturities of the Company’s operating lease liabilities and other lease information. (dollars in thousands) Twelve months ended March 31, Lease Liability 2021 $ 245 2022 157 2023 126 2024 45 2025 45 After March 31, 2025 120 Total lease payments $ 738 Less: interest (43) Present value of lease liabilities $ 695
Lessee, Operating Lease, Supplemental Lease Information	(dollars in thousands) Supplemental lease information: March 31, 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases (cash payments) $ 50 Operating cash flows from operating leases (lease liability reduction) 42 Operating lease right-of-use assets obtained in exchange for leases entered into during the period 195

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following table presents information regarding the Company’s outstanding borrowings at March 31, 2020 and December 31, 2019: (dollars in thousands) March 31, 2020 December 31, 2019 Federal Home Loan Bank advances $ 36,500 $ 47,000 Other borrowings 14,563 14,563 $ 51,063 $ 61,563
Schedule of Maturities of Long-term Debt	The aggregate stated maturities of other borrowed money at March 31, 2020 are as follows: (in thousands) Year Amount 2021 $ 5,313 2022 14,000 2023 3,000 2024 9,250 2025 and After 19,500 $ 51,063

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents earnings per share for the three month period ended March 31, 2020 and 2019. (dollars in thousands except per share data) Three Months Ended 2020 2019 Numerator Net income available to common stockholders $ 1,603 $ 2,835 Denominator Weighted average number of common shares Outstanding for basic earnings per common share 9,499 8,440 Weighted-average number of shares outstanding for diluted earnings per common share 9,499 8,440 Earnings per share - basic $ 0.17 $ 0.34 Earnings per share - diluted $ 0.17 $ 0.34

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Summary Of Financial Instrument Outstanding	At March 31, 2020 and December 31, 2019 the following financial instruments were outstanding whose contract amounts represent credit risk: Contract Amount (dollars in thousands) March 31, 2020 December 31, 2019 Loan commitments $ 147,433 $ 102,890 Letters of credit 2,626 1,576

Fair Value of Financial Instr_2

Fair Value of Financial Instruments and Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value, by Balance Sheet Grouping	The carrying amount, estimated fair values, and placement in the fair value hierarchy of the Company’s financial instruments as of March 31, 2020 and December 31, 2019 are as follows: (dollars in thousands) Fair Value Measurements Carrying Estimated Level Level Level March 31, 2020 Assets Cash and short-term investments $ 95,827 $ 95,827 $ 95,827 $ — $ — Investment securities available for sale 333,085 333,085 — 331,068 2,017 Other investments, at cost 3,891 3,891 3,162 729 — Loans held for sale 11,022 11,022 — 11,022 — Loans, net 980,642 1,003,928 — — 1,003,928 Liabilities Deposits 1,293,076 1,293,076 — 1,293,076 — Subordinated debentures 24,229 24,229 — 24,229 — Other borrowings 51,063 48,465 — 48,465 (dollars in thousands) Fair Value Measurements Carrying Estimated Level Level Level December 31, 2019 Assets Cash and short-term investments $ 104,092 $ 104,092 $ 104,192 $ — $ — Investment securities available for sale 347,332 347,332 — 345,310 2,022 Other investments, at cost 4,288 4,288 3,559 729 — Loans held for sale 10,076 10,076 — 10,076 — Loans, net 961,696 938,475 — — 938,475 Liabilities Deposits 1,293,742 1,294,506 — 1,294,506 — Subordinated debentures 24,229 24,229 — 24,229 — Other borrowings 61,563 60,585 — 60,585 —
Fair Value Measurements, Recurring and Nonrecurring	The following table presents the recorded amount of the Company’s assets measured at fair value on a recurring and nonrecurring basis as of March 31, 2020 and December 31, 2019, aggregated by the level in the fair value hierarchy within which those measurements fall. The table below includes only impaired loans with a specific reserve and only other real estate properties with a valuation allowance at March 31, 2020 and December 31, 2019. Those impaired loans and other real estate properties are shown net of the related specific reserves and valuation allowances. (dollars in thousands) Fair Value Measurements at Reporting Date Using March 31, 2020 Total Fair Value Quoted Prices in Significant Other Significant Recurring Securities Available for Sale State, county & municipal securities $ 6,410 $ — $ 6,410 $ — Corporate Debt securities 2,017 — — 2,017 Mortgage-backed securities 324,658 — 324,658 — Total available for sale securities $ 333,085 $ — $ 331,068 $ 2,017 Nonrecurring Collateral Dependent Impaired Loans 4,509 — — 4,509 Other Real Estate 847 — — 847 Total nonrecurring assets $ 5,356 $ — $ — $ 5,356 (dollars in thousands) Fair Value Measurements at Reporting Date Using December 31, 2019 Total Fair Quoted Prices in Significant Other Significant Recurring Securities Available for Sale State, county & municipal securities $ 5,115 $ — $ 5,115 $ — Corporate Debt securities 2,806 — 784 2,022 Mortgage-backed securities 339,411 — 339,411 — Total available for sale securities $ 347,332 $ — $ 345,310 $ 2,022 Nonrecurring Collateral Dependent Impaired Loans 5,985 — — 5,985 Other Real Estate 1,320 — — 1,320 Total nonrecurring assets $ 7,305 $ — $ — $ 7,305
Fair Value Measurement Inputs and Valuation Techniques	The following table presents quantitative information about the significant unobservable inputs used in the fair value measurements for assets in level 3 of the fair value hierarchy measured on a nonrecurring basis at March 31, 2020 and December 31, 2019. This table is comprised primarily of collateral dependent impaired loans and other real estate: (dollars in thousands) March 31, 2020 Valuation Unobservable Range Collateral Dependent Impaired Loans $ 4,509 Appraised Value Discounts to reflect current market conditions, ultimate collectability, and estimated costs to sell 10 % 50 % Other Real Estate 847 Appraised Value/Comparable Sales Discounts to reflect current market conditions and estimated costs to sell — % 20 % (dollars in thousands) December 31, 2019 Valuation Unobservable Range Collateral Dependent Impaired Loans $ 5,985 Appraised Value Discounts to reflect current market conditions, ultimate collectability, and estimated costs to sell — % 20 % Other Real Estate 1,320 Appraised Value/Comparable Sales Discounts to reflect current market conditions and estimated costs to sell — % 20 % The following table presents quantitative information about recurring level 3 fair value measurements as of March 31, 2020. (dollars in thousands) March 31, 2020 Fair Value Valuation Techniques Unobservable Range Corporate debt securities $ 2,017 Discounted Cash Flow Discount Rate or Yield N/A* December 31, 2019 Corporate debt securities $ 2,022 Discounted Cash Flow Discount Rate or Yield N/A* * The Company relies on a third-party pricing service to value its securities. The details of the unobservable inputs and other adjustments used by the third-party pricing service were not readily available to the Company.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	The table below presents a reconciliation and statement of income classification of gains and losses for all assets measured at fair value on a recurring basis using significant unobservable inputs (level 3) for the three months ended March 31, 2020 and 2019. (dollars in thousands) Available for Sale Securities March 31, 2020 March 31, 2019 Balance, Beginning $ 2,022 $ 4,277 Transfers out of Level 3 — — Sales — — Paydowns (5) (390) Realized Loss on Sale of Security — — Unrealized gains included in Other Comprehensive Income — 10 Balance, Ending $ 2,017 $ 3,897

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	(dollars in thousands) Bank Mortgage Small Totals Three Months Ended March 31, 2020 Net Interest Income $ 12,656 $ 34 $ 14 $ 12,704 Provision for Loan Losses 1,956 — — 1,956 Noninterest Income 3,049 1,253 259 4,561 Noninterest Expenses 11,667 1,195 516 13,378 Income Taxes 368 11 (51) 328 Segment Profit (Loss) $ 1,714 $ 81 $ (192) $ 1,603 Segments Assets at March 31, 2020 $ 1,497,788 $ 11,082 $ 1,178 $ 1,510,048 (dollars in thousands) Bank Mortgage Small Totals Three Months Ended March 31, 2019 Net Interest Income $ 10,357 $ — $ — $ 10,357 Provision for Loan Losses 131 — — 131 Noninterest Income 2,334 — — 2,334 Noninterest Expenses 9,026 — — 9,026 Income Taxes 699 — — 699 Segment Profit $ 2,835 $ — $ — $ 2,835 Segments Assets at March 31, 2019 $ 1,503,284 $ 11,624 $ 405 $ 1,515,313

Regulatory Capital Matters (Tab

Regulatory Capital Matters (Tables)	3 Months Ended
	Mar. 31, 2020
Banking and Thrift [Abstract]
Schedule of Compliance with Regulatory Capital Requirements under Banking Regulations	The following table summarizes regulatory capital information as of March 31, 2020 and December 31, 2019 on a consolidated basis and for the subsidiary, as defined. Regulatory capital ratios for March 31, 2020 and December 31, 2019 were calculated in accordance with the Basel III rules. (dollars in thousands) Actual For Capital To Be Well Amount Ratio Amount Ratio Amount Ratio As of March 31, 2020 Total Capital to Risk-Weighted Assets Consolidated $ 138,789 13.47 % $ 82,429 8.00 % N/A N/A Colony Bank 148,961 13.98 85,242 8.00 $ 106,553 10.00 % Tier I Capital to Risk-Weighted Assets Consolidated 132,189 12.68 62,550 6.00 N/A N/A Colony Bank 140,577 13.19 63,947 6.00 85,263 8.00 Common Equity Tier I Capital to Risk-Weighted Assets Consolidated 108,689 10.47 46,714 4.50 N/A N/A Colony Bank 140,577 13.19 47,960 4.50 69,276 6.50 Tier I Capital to Average Assets Consolidated 132,189 9.06 58,362 4.00 N/A N/A Colony Bank 140,577 9.46 59,441 4.00 74,301 5.00 (dollars in thousands) Actual For Capital To Be Well Amount Ratio Amount Ratio Amount Ratio As of December 31, 2019 Total Capital to Risk-Weighted Assets Consolidated $ 140,973 13.17 % $ 85,661 8.00 % N/A N/A Colony Bank 151,444 14.19 85,407 8.00 $ 106,758 10.00 % Tier I Capital to Risk-Weighted Assets Consolidated 134,110 12.52 64,246 6.00 N/A N/A Colony Bank 144,581 13.54 64,055 6.00 8,547 8.00 Common Equity Tier I Capital to Risk-Weighted Assets Consolidated 110,610 10.33 48,185 4.50 N/A N/A Colony Bank 144,581 13.54 48,041 4.50 69,393 6.50 Tier I Capital to Average Assets Consolidated 134,110 8.92 60,141 4.00 N/A N/A Colony Bank 144,581 9.77 59,977 4.00 74,972 5.00

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Percentage of Loan Portfolio Concentrated in Loans Secured by Real Estate	86.00%

Business Acquisitions (Details

Business Acquisitions (Details Textual) $ / shares in Units, $ in Thousands	May 01, 2019USD ($)bank$ / sharesshares	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Business Acquisition [Line Items]
Goodwill		$ 16,477	$ 16,477
LBC Bancshares, Inc
Business Acquisition [Line Items]
Number of banking locations | bank	2
Share price (in dollars per share) | $ / shares	$ 23.50
Number of shares received for each share of LBC common stock | shares	1.3239
Stock consideration received, percentage of shares	55.00%
Cash consideration received, percentage of shares	45.00%
Minimum percentage of merger consideration paid	50.00%
Share of stock issued (in shares) | shares	1,053,875
Fair value of shares issued	$ 18,706
Cash consideration paid	15,315
Goodwill	15,734
Loans purchased at fair value	130,568
Discount on loans purchased	$ 2,200
Discount on loans purchased, percentage of loan value	1.63%
Credit impaired loans acquired	$ 176
LBC Bancshares, Inc | LaGrange, Georgia
Business Acquisition [Line Items]
Number of banking locations | bank	1
LBC Bancshares, Inc | Columbus, Georgia
Business Acquisition [Line Items]
Number of banking locations | bank	1
PFB Mortgage
Business Acquisition [Line Items]
Cash consideration paid	$ 833
Goodwill	$ 541

Business Acquisitions - Assets

Business Acquisitions - Assets and Liabilities Acquired (Details) - USD ($) $ / shares in Units, $ in Thousands	May 01, 2019	Mar. 31, 2020	Dec. 31, 2019
Assets acquired at fair value:
Amount of goodwill resulting from acquisition		$ 16,477	$ 16,477
LBC Bancshares, Inc
Purchase price consideration (dollars in thousands):
Shares of CBAN common stock issued to LBC shareholders as of May 1, 2019	1,053,875
Market Price of CBAN Common Stock on May 1, 2019 (in dollars per share)	$ 17.75
Estimated fair value of CBAN common stock issued	$ 18,706
Cash consideration paid	15,315
Total purchase price for PFB branch acquisition	34,021
Assets acquired at fair value:
Cash and cash equivalents	15,678
Investments securities available for sale	49,172
Investments securities held to maturity	1,766
Restricted investments	479
Loans	130,568
Premises and equipment	3,009
Core deposit intangible	3,100
Other real estate	243
Prepaid and other assets	6,143
Total fair value of assets acquired	210,158
Deposits	(189,896)
FHLB advances	(1,000)
Payables and other liabilities	(975)
Total fair value of liabilities assumed	(191,871)
Net assets acquired at fair value:	18,287
Amount of goodwill resulting from acquisition	15,734
PFB Mortgage
Purchase price consideration (dollars in thousands):
Cash consideration paid	833
Total purchase price for PFB branch acquisition	833
Assets acquired at fair value:
Premises and equipment	78
Premium on loan commitments	209
Other assets	5
Total fair value of assets acquired	292
Total fair value of liabilities assumed	0
Net assets acquired at fair value:	292
Amount of goodwill resulting from acquisition	$ 541

Business Acquisitions - Contrac

Business Acquisitions - Contractually Required Principal and Interest Cash Payments (Details) - LBC Bancshares, Inc $ in Thousands	May 01, 2019USD ($)
Business Acquisition [Line Items]
Contractually required principal and interest	$ 695
Non-accretable difference	(519)
Cash Flows expected to be collected	176
Accretable yield	0
Total purchased credit-impaired loans acquired	$ 176

Business Acquisitions - Loan Da

Business Acquisitions - Loan Data for the LBC Acquisition (Details) - LBC Bancshares, Inc $ in Thousands	May 01, 2019USD ($)
Acquired receivables subject to ASC 310-30
Fair Value of Acquired Loans at Acquisition Date	$ 176
Gross Contractual Amounts Receivable at Acquisition Date	695
Estimate at Acquisition Date of Contractual Cash Flows Not Expected to be Collected	519
Acquired receivables not subject to ASC 310-30
Fair Value of Acquired Loans at Acquisition Date	130,392
Gross Contractual Amounts Receivable at Acquisition Date	132,381
Estimate at Acquisition Date of Contractual Cash Flows Not Expected to be Collected	$ 0

Investment Securities - Schedul

Investment Securities - Schedule of Investment Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Securities Available for Sale:
Amortized cost	$ 326,418	$ 346,874
Gross Unrealized Gains	8,078	2,716
Gross Unrealized Losses	(1,411)	(2,258)
Investment securities available for sale, at fair value	333,085	347,332
State, county & municipal securities
Securities Available for Sale:
Amortized cost	6,296	5,133
Gross Unrealized Gains	135	36
Gross Unrealized Losses	(21)	(54)
Investment securities available for sale, at fair value	6,410	5,115
Corporate Debt securities
Securities Available for Sale:
Amortized cost	2,007	2,811
Gross Unrealized Gains	10	11
Gross Unrealized Losses	0	(16)
Investment securities available for sale, at fair value	2,017	2,806
Mortgage-backed securities
Securities Available for Sale:
Amortized cost	318,115	338,930
Gross Unrealized Gains	7,933	2,669
Gross Unrealized Losses	(1,390)	(2,188)
Investment securities available for sale, at fair value	$ 324,658	$ 339,411

Investment Securities - Amortiz

Investment Securities - Amortized Cost and Fair Value of Investment Securities by Contractual Maturity (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Amortized Cost
Due in one year or less	$ 145
Due after one year through five years	3,633
Due after five years through ten years	723
Due after ten years	3,802
Debt Securities With Single Maturity Date, Amortized Cost	8,303
Mortgage-backed securities	318,115
Amortized cost	326,418	$ 346,874
Fair Value
Due In One Year or Less	147
Due After One Year Through Five Years	3,640
Due After Five Years Through Ten Years	761
Due After Ten Years	3,879
Debt Securities With Single Maturity Date, Fair Value	8,427
Mortgage-Backed Securities	324,658
Fair Value	$ 333,085	$ 347,332

Investment Securities (Details

Investment Securities (Details Textual)	3 Months Ended
	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)
Investments, Debt and Equity Securities [Abstract]
Proceeds from the sale of investments	$ 15,300,000	$ 0
Gross realized gain on sale	355,000
Gross realized loss on sale	62,000
Investment securities pledged as collateral	$ 118,100,000		$ 122,300,000
Number of securities in unrealized loss positions	22
Securities deemed to be other than temporary	$ 0

Investment Securities - Continu

Investment Securities - Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Gross Unrealized Losses
Less Than 12 Months	$ (370)	$ (331)
12 Months or Greater	(1,041)	(1,927)
Total	(1,411)	(2,258)
Fair Value
Less Than 12 Months	19,181	64,117
12 Months or Greater	18,403	119,894
Fair Value	37,584	184,011
State, county & municipal securities
Gross Unrealized Losses
Less Than 12 Months	(21)	(54)
12 Months or Greater	0	0
Total	(21)	(54)
Fair Value
Less Than 12 Months	1,352	3,257
12 Months or Greater	0	0
Fair Value	1,352	3,257
Corporate debt securities
Gross Unrealized Losses
Less Than 12 Months	0	0
12 Months or Greater	0	(16)
Total	0	(16)
Fair Value
Less Than 12 Months	0	0
12 Months or Greater	0	784
Fair Value	0	784
Mortgage-backed securities
Gross Unrealized Losses
Less Than 12 Months	(349)	(277)
12 Months or Greater	(1,041)	(1,911)
Total	(1,390)	(2,188)
Fair Value
Less Than 12 Months	17,829	60,860
12 Months or Greater	18,403	119,110
Fair Value	$ 36,232	$ 179,970

Loans - Segregated by Class of

Loans - Segregated by Class of Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Loans	$ 989,026	$ 968,814	$ 968,814
Legacy Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	840,652	847,100
Purchased Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	148,374	121,714
Construction, land and land development
Loans and Leases Receivable Disclosure [Line Items]
Loans	134,037		96,097
Other commercial real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	524,484		540,239
Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	190,969	194,796	194,796
Residential real estate | Legacy Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	169,199	171,341
Residential real estate | Purchased Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	21,770	23,455
Commercial, financial, & agricultural
Loans and Leases Receivable Disclosure [Line Items]
Loans	116,786	114,360	114,360
Commercial, financial, & agricultural | Legacy Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	99,121	91,535
Commercial, financial, & agricultural | Purchased Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	17,665	22,825
Consumer and other
Loans and Leases Receivable Disclosure [Line Items]
Loans	22,750	23,322	$ 23,322
Consumer and other | Legacy Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	19,303	19,245
Consumer and other | Purchased Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	3,447	4,077
Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	658,521	636,336
Commercial Real Estate Portfolio Segment | Legacy Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	553,029	564,979
Commercial Real Estate Portfolio Segment | Purchased Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	105,492	71,357
Commercial Real Estate Portfolio Segment | Construction, land and land development
Loans and Leases Receivable Disclosure [Line Items]
Loans	134,037	96,097
Commercial Real Estate Portfolio Segment | Construction, land and land development | Legacy Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	86,268	83,036
Commercial Real Estate Portfolio Segment | Construction, land and land development | Purchased Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	47,769	13,061
Commercial Real Estate Portfolio Segment | Other commercial real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	524,484	540,239
Commercial Real Estate Portfolio Segment | Other commercial real estate | Legacy Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	466,761	481,943
Commercial Real Estate Portfolio Segment | Other commercial real estate | Purchased Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	$ 57,723	$ 58,296

Loans - Loan Portfolio by Credi

Loans - Loan Portfolio by Credit Quality Indicator (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Loans	$ 989,026	$ 968,814	$ 968,814
Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	658,521	636,336
Construction, land and land development
Loans and Leases Receivable Disclosure [Line Items]
Loans	134,037		96,097
Construction, land and land development | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	134,037	96,097
Other commercial real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	524,484		540,239
Other commercial real estate | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	524,484	540,239
Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	190,969	194,796	194,796
Commercial, financial, & agricultural
Loans and Leases Receivable Disclosure [Line Items]
Loans	116,786	114,360	114,360
Consumer and other
Loans and Leases Receivable Disclosure [Line Items]
Loans	22,750	23,322	$ 23,322
Legacy Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	840,652	847,100
Legacy Loans | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	553,029	564,979
Legacy Loans | Construction, land and land development | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	86,268	83,036
Legacy Loans | Other commercial real estate | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	466,761	481,943
Legacy Loans | Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	169,199	171,341
Legacy Loans | Commercial, financial, & agricultural
Loans and Leases Receivable Disclosure [Line Items]
Loans	99,121	91,535
Legacy Loans | Consumer and other
Loans and Leases Receivable Disclosure [Line Items]
Loans	19,303	19,245
Purchased Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	148,374	121,714
Purchased Loans | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	105,492	71,357
Purchased Loans | Construction, land and land development | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	47,769	13,061
Purchased Loans | Other commercial real estate | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	57,723	58,296
Purchased Loans | Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	21,770	23,455
Purchased Loans | Commercial, financial, & agricultural
Loans and Leases Receivable Disclosure [Line Items]
Loans	17,665	22,825
Purchased Loans | Consumer and other
Loans and Leases Receivable Disclosure [Line Items]
Loans	3,447	4,077
Pass | Legacy Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	802,445	806,021
Pass | Legacy Loans | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	531,118	541,386
Pass | Legacy Loans | Construction, land and land development | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	85,515	82,322
Pass | Legacy Loans | Other commercial real estate | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	445,603	459,064
Pass | Legacy Loans | Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	157,935	159,194
Pass | Legacy Loans | Commercial, financial, & agricultural
Loans and Leases Receivable Disclosure [Line Items]
Loans	94,465	86,558
Pass | Legacy Loans | Consumer and other
Loans and Leases Receivable Disclosure [Line Items]
Loans	18,927	18,883
Pass | Purchased Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	139,982	117,494
Pass | Purchased Loans | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	100,853	70,877
Pass | Purchased Loans | Construction, land and land development | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	45,953	12,996
Pass | Purchased Loans | Other commercial real estate | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	54,900	57,881
Pass | Purchased Loans | Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	21,348	23,097
Pass | Purchased Loans | Commercial, financial, & agricultural
Loans and Leases Receivable Disclosure [Line Items]
Loans	14,525	19,443
Pass | Purchased Loans | Consumer and other
Loans and Leases Receivable Disclosure [Line Items]
Loans	3,256	4,077
Special Mention | Legacy Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	17,941	34,519
Special Mention | Legacy Loans | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	11,554	13,883
Special Mention | Legacy Loans | Construction, land and land development | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	431	445
Special Mention | Legacy Loans | Other commercial real estate | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	11,123	13,438
Special Mention | Legacy Loans | Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	4,496	4,632
Special Mention | Legacy Loans | Commercial, financial, & agricultural
Loans and Leases Receivable Disclosure [Line Items]
Loans	1,713	1,973
Special Mention | Legacy Loans | Consumer and other
Loans and Leases Receivable Disclosure [Line Items]
Loans	178	148
Special Mention | Purchased Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	5,565	3,579
Special Mention | Purchased Loans | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	2,277	381
Special Mention | Purchased Loans | Construction, land and land development | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	1,698	0
Special Mention | Purchased Loans | Other commercial real estate | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	579	381
Special Mention | Purchased Loans | Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	307	249
Special Mention | Purchased Loans | Commercial, financial, & agricultural
Loans and Leases Receivable Disclosure [Line Items]
Loans	2,981	2,949
Special Mention | Purchased Loans | Consumer and other
Loans and Leases Receivable Disclosure [Line Items]
Loans	0	0
Substandard | Legacy Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	20,266	20,443
Substandard | Legacy Loans | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	10,357	9,710
Substandard | Legacy Loans | Construction, land and land development | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	322	269
Substandard | Legacy Loans | Other commercial real estate | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	10,035	9,441
Substandard | Legacy Loans | Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	6,768	7,515
Substandard | Legacy Loans | Commercial, financial, & agricultural
Loans and Leases Receivable Disclosure [Line Items]
Loans	2,943	3,004
Substandard | Legacy Loans | Consumer and other
Loans and Leases Receivable Disclosure [Line Items]
Loans	198	214
Substandard | Purchased Loans
Loans and Leases Receivable Disclosure [Line Items]
Loans	2,827	641
Substandard | Purchased Loans | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	2,362	99
Substandard | Purchased Loans | Construction, land and land development | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	118	65
Substandard | Purchased Loans | Other commercial real estate | Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Loans	2,244	34
Substandard | Purchased Loans | Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Loans	115	109
Substandard | Purchased Loans | Commercial, financial, & agricultural
Loans and Leases Receivable Disclosure [Line Items]
Loans	159	433
Substandard | Purchased Loans | Consumer and other
Loans and Leases Receivable Disclosure [Line Items]
Loans	$ 191	$ 0

Loans (Details Textual)

Loans (Details Textual)	3 Months Ended
	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)
Receivables [Abstract]
Outstanding balance of high risk loans, minimum			$ 250,000
Interest income on impaired loans	$ 50,000	$ 43,000
Unfunded commitments to lend	$ 0
Loan contracts restructured	0

Loans - Age Analysis of Past Du

Loans - Age Analysis of Past Due Loans and Nonaccrual Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Financing Receivable, Past Due [Line Items]
Loans	$ 989,026	$ 968,814	$ 968,814
Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	3,962	1,914
Nonaccrual Loans	10,130	9,179
Current Loans	826,560	836,007
Loans	840,652	847,100
Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	683	701
Nonaccrual Loans	0	0
Current Loans	147,691	121,013
Loans	148,374	121,714
30-89 Days Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	3,962	1,914
30-89 Days Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	683	701
90 Days or More Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
90 Days or More Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Residential real estate
Financing Receivable, Past Due [Line Items]
Loans	190,969	194,796	194,796
Residential real estate | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	1,635	1,296
Nonaccrual Loans	3,336	3,643
Current Loans	164,228	166,402
Loans	169,199	171,341
Residential real estate | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	57
Nonaccrual Loans	0	0
Current Loans	21,770	23,398
Loans	21,770	23,455
Residential real estate | 30-89 Days Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	1,635	1,296
Residential real estate | 30-89 Days Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	57
Residential real estate | 90 Days or More Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Residential real estate | 90 Days or More Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Commercial, financial, & agricultural
Financing Receivable, Past Due [Line Items]
Loans	116,786	114,360	114,360
Commercial, financial, & agricultural | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	531	212
Nonaccrual Loans	2,779	1,628
Current Loans	95,811	89,695
Loans	99,121	91,535
Commercial, financial, & agricultural | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	553
Nonaccrual Loans	0	0
Current Loans	17,665	22,272
Loans	17,665	22,825
Commercial, financial, & agricultural | 30-89 Days Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	531	212
Commercial, financial, & agricultural | 30-89 Days Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	553
Commercial, financial, & agricultural | 90 Days or More Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Commercial, financial, & agricultural | 90 Days or More Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Consumer and other
Financing Receivable, Past Due [Line Items]
Loans	22,750	23,322	23,322
Consumer and other | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	113	21
Nonaccrual Loans	129	138
Current Loans	19,061	19,086
Loans	19,303	19,245
Consumer and other | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	4	8
Nonaccrual Loans	0	0
Current Loans	3,443	4,069
Loans	3,447	4,077
Consumer and other | 30-89 Days Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	113	21
Consumer and other | 30-89 Days Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	4	8
Consumer and other | 90 Days or More Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Consumer and other | 90 Days or More Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Construction, land and land development
Financing Receivable, Past Due [Line Items]
Loans	134,037		96,097
Other commercial real estate
Financing Receivable, Past Due [Line Items]
Loans	524,484		$ 540,239
Commercial Real Estate Portfolio Segment
Financing Receivable, Past Due [Line Items]
Loans	658,521	636,336
Commercial Real Estate Portfolio Segment | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	1,683	385
Nonaccrual Loans	3,886	3,770
Current Loans	547,460	560,824
Loans	553,029	564,979
Commercial Real Estate Portfolio Segment | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	679	83
Nonaccrual Loans	0	0
Current Loans	104,813	71,274
Loans	105,492	71,357
Commercial Real Estate Portfolio Segment | 30-89 Days Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	1,683	385
Commercial Real Estate Portfolio Segment | 30-89 Days Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	679	83
Commercial Real Estate Portfolio Segment | 90 Days or More Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Commercial Real Estate Portfolio Segment | 90 Days or More Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Commercial Real Estate Portfolio Segment | Construction, land and land development
Financing Receivable, Past Due [Line Items]
Loans	134,037	96,097
Commercial Real Estate Portfolio Segment | Construction, land and land development | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	293	50
Nonaccrual Loans	81	32
Current Loans	85,894	82,954
Loans	86,268	83,036
Commercial Real Estate Portfolio Segment | Construction, land and land development | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	679	0
Nonaccrual Loans	0	0
Current Loans	47,090	13,061
Loans	47,769	13,061
Commercial Real Estate Portfolio Segment | Construction, land and land development | 30-89 Days Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	293	50
Commercial Real Estate Portfolio Segment | Construction, land and land development | 30-89 Days Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	679	0
Commercial Real Estate Portfolio Segment | Construction, land and land development | 90 Days or More Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Commercial Real Estate Portfolio Segment | Construction, land and land development | 90 Days or More Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Commercial Real Estate Portfolio Segment | Other commercial real estate
Financing Receivable, Past Due [Line Items]
Loans	524,484	540,239
Commercial Real Estate Portfolio Segment | Other commercial real estate | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	1,390	335
Nonaccrual Loans	3,805	3,738
Current Loans	461,566	477,870
Loans	466,761	481,943
Commercial Real Estate Portfolio Segment | Other commercial real estate | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	83
Nonaccrual Loans	0	0
Current Loans	57,723	58,213
Loans	57,723	58,296
Commercial Real Estate Portfolio Segment | Other commercial real estate | 30-89 Days Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	1,390	335
Commercial Real Estate Portfolio Segment | Other commercial real estate | 30-89 Days Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	83
Commercial Real Estate Portfolio Segment | Other commercial real estate | 90 Days or More Past Due | Legacy Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	0	0
Commercial Real Estate Portfolio Segment | Other commercial real estate | 90 Days or More Past Due | Purchased Loans
Financing Receivable, Past Due [Line Items]
Accruing Loans Past Due	$ 0	$ 0

Loans - Impaired Loan Data (Det

Loans - Impaired Loan Data (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Unpaid Contractual Principal Balance
With No Related Allowance Recorded	$ 16,048	$ 15,485
With An Allowance Recorded	8,835	9,325
Loans Including Purchased Credit Impaired Loans	25,398	24,957
Impaired Balance
With No Related Allowance Recorded	15,171	14,674
With An Allowance Recorded	8,835	9,134
Loans Including Purchased Credit Impaired Loans	24,521	23,955
Related Allowance
With An Allowance Recorded	3,157	3,149
Total Impaired Loans	3,257	3,155
Average Recorded Investment
With No Related Allowance Recorded	15,329	18,818
With An Allowance Recorded	9,081	5,067
Loans Including Purchased Credit Impaired Loans	24,740	24,071
Financial Asset Acquired with Credit Deterioration
Unpaid Contractual Principal Balance
Loans Including Purchased Credit Impaired Loans	515	147
Impaired Balance
Loans Including Purchased Credit Impaired Loans	515	147
Related Allowance
Purchased Credit Impaired Loans	100	6
Average Recorded Investment
Loans Including Purchased Credit Impaired Loans	330	186
Construction, land and land development
Unpaid Contractual Principal Balance
With No Related Allowance Recorded	66	67
With An Allowance Recorded	0	0
Loans Including Purchased Credit Impaired Loans	185	132
Impaired Balance
With No Related Allowance Recorded	66	67
With An Allowance Recorded	0	0
Loans Including Purchased Credit Impaired Loans	185	132
Related Allowance
With An Allowance Recorded	0	0
Total Impaired Loans	0	0
Average Recorded Investment
With No Related Allowance Recorded	67	168
With An Allowance Recorded	0	80
Loans Including Purchased Credit Impaired Loans	159	328
Construction, land and land development | Financial Asset Acquired with Credit Deterioration
Unpaid Contractual Principal Balance
Loans Including Purchased Credit Impaired Loans	119	65
Impaired Balance
Loans Including Purchased Credit Impaired Loans	119	65
Related Allowance
Purchased Credit Impaired Loans	0	0
Average Recorded Investment
Loans Including Purchased Credit Impaired Loans	92	80
Residential real estate
Unpaid Contractual Principal Balance
With No Related Allowance Recorded	2,477	2,706
With An Allowance Recorded	525	757
Loans Including Purchased Credit Impaired Loans	3,020	3,474
Impaired Balance
With No Related Allowance Recorded	2,465	2,711
With An Allowance Recorded	525	760
Loans Including Purchased Credit Impaired Loans	3,008	3,482
Related Allowance
With An Allowance Recorded	99	137
Total Impaired Loans	111	143
Average Recorded Investment
With No Related Allowance Recorded	2,586	3,693
With An Allowance Recorded	641	367
Loans Including Purchased Credit Impaired Loans	3,242	4,084
Residential real estate | Financial Asset Acquired with Credit Deterioration
Unpaid Contractual Principal Balance
Loans Including Purchased Credit Impaired Loans	18	11
Impaired Balance
Loans Including Purchased Credit Impaired Loans	18	11
Related Allowance
Purchased Credit Impaired Loans	12	6
Average Recorded Investment
Loans Including Purchased Credit Impaired Loans	15	24
Commercial, financial, & agricultural
Unpaid Contractual Principal Balance
With No Related Allowance Recorded	381	257
With An Allowance Recorded	1,974	2,189
Loans Including Purchased Credit Impaired Loans	2,417	2,483
Impaired Balance
With No Related Allowance Recorded	381	257
With An Allowance Recorded	1,974	1,989
Loans Including Purchased Credit Impaired Loans	2,417	2,283
Related Allowance
With An Allowance Recorded	981	1,073
Total Impaired Loans	981	1,073
Average Recorded Investment
With No Related Allowance Recorded	319	910
With An Allowance Recorded	2,082	722
Loans Including Purchased Credit Impaired Loans	2,450	1,679
Commercial, financial, & agricultural | Financial Asset Acquired with Credit Deterioration
Unpaid Contractual Principal Balance
Loans Including Purchased Credit Impaired Loans	62	37
Impaired Balance
Loans Including Purchased Credit Impaired Loans	62	37
Related Allowance
Purchased Credit Impaired Loans	0	0
Average Recorded Investment
Loans Including Purchased Credit Impaired Loans	49	47
Consumer and other
Unpaid Contractual Principal Balance
With No Related Allowance Recorded	0	0
With An Allowance Recorded	0	0
Loans Including Purchased Credit Impaired Loans	191	0
Impaired Balance
With No Related Allowance Recorded	0	0
With An Allowance Recorded	0	0
Loans Including Purchased Credit Impaired Loans	191	0
Related Allowance
With An Allowance Recorded	0	0
Total Impaired Loans	88	0
Average Recorded Investment
With No Related Allowance Recorded	0	123
With An Allowance Recorded	0	0
Loans Including Purchased Credit Impaired Loans	95	123
Consumer and other | Financial Asset Acquired with Credit Deterioration
Unpaid Contractual Principal Balance
Loans Including Purchased Credit Impaired Loans	191	0
Impaired Balance
Loans Including Purchased Credit Impaired Loans	191	0
Related Allowance
Purchased Credit Impaired Loans	88	0
Average Recorded Investment
Loans Including Purchased Credit Impaired Loans	95	0
Commercial Real Estate Portfolio Segment
Unpaid Contractual Principal Balance
With No Related Allowance Recorded	13,124	12,455
With An Allowance Recorded	6,336	6,379
Loans Including Purchased Credit Impaired Loans	19,585	18,868
Impaired Balance
With No Related Allowance Recorded	12,259	11,639
With An Allowance Recorded	6,336	6,385
Loans Including Purchased Credit Impaired Loans	18,720	18,058
Related Allowance
With An Allowance Recorded	2,077	1,939
Total Impaired Loans	2,077	1,939
Average Recorded Investment
With No Related Allowance Recorded	12,357	13,924
With An Allowance Recorded	6,358	3,898
Loans Including Purchased Credit Impaired Loans	18,794	17,857
Commercial Real Estate Portfolio Segment | Financial Asset Acquired with Credit Deterioration
Unpaid Contractual Principal Balance
Loans Including Purchased Credit Impaired Loans	125	34
Impaired Balance
Loans Including Purchased Credit Impaired Loans	125	34
Related Allowance
Purchased Credit Impaired Loans	0	0
Average Recorded Investment
Loans Including Purchased Credit Impaired Loans	$ 79	$ 35

Allowance for Loan Losses (Deta

Allowance for Loan Losses (Details Textual)	Dec. 31, 2019USD ($)
Receivables [Abstract]
Outstanding balance of high risk loans, minimum	$ 250,000

Allowance for Loan Losses - Seg

Allowance for Loan Losses - Segregated by Class of Loan (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 6,863	$ 7,277
Charge-offs	(513)	(944)
Recoveries	78	125
Provision	1,956	131
Ending balance	8,384	6,589
Period end amount allocated to
Individually evaluated for impairment	3,157		$ 3,149
Collectively evaluated for impairment	5,127		3,708
Loans
Individually evaluated for impairment	24,006	23,808
Collectively evaluated for impairment	964,505	944,859
Loans	989,026	968,814	968,814
Financial Asset Acquired with Credit Deterioration
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	6
Ending balance	100
Loans
Loans	515	147
Construction, land and land development
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	215	131
Charge-offs	0	(29)
Recoveries	13	17
Provision	126	(99)
Ending balance	354	20
Period end amount allocated to
Individually evaluated for impairment	0		0
Collectively evaluated for impairment	354		215
Loans
Individually evaluated for impairment	66	67
Collectively evaluated for impairment	133,852	95,965
Loans	134,037	96,097
Construction, land and land development | Financial Asset Acquired with Credit Deterioration
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0
Ending balance	0
Loans
Loans	119	65
Other commercial real estate
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	3,908	5,251
Charge-offs	(30)	(119)
Recoveries	5	34
Provision	938	(104)
Ending balance	4,821	5,062
Period end amount allocated to
Individually evaluated for impairment	2,077		1,939
Collectively evaluated for impairment	2,744		1,969
Loans
Individually evaluated for impairment	18,595	18,024
Collectively evaluated for impairment	505,764	522,181
Loans	524,484	540,239
Other commercial real estate | Financial Asset Acquired with Credit Deterioration
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0
Ending balance	0
Loans
Loans	125	34
Residential real estate
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	980	1,181
Charge-offs	(64)	(629)
Recoveries	4	49
Provision	283	348
Ending balance	1,203	949
Period end amount allocated to
Individually evaluated for impairment	99		137
Collectively evaluated for impairment	1,092		837
Loans
Individually evaluated for impairment	2,990	3,471
Collectively evaluated for impairment	187,961	191,314
Loans	190,969	194,796	194,796
Residential real estate | Financial Asset Acquired with Credit Deterioration
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	6
Ending balance	12
Loans
Loans	18	11
Commercial, financial, & agricultural
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	1,657	618
Charge-offs	(68)	(97)
Recoveries	1	6
Provision	190	(61)
Ending balance	1,780	466
Period end amount allocated to
Individually evaluated for impairment	981		1,073
Collectively evaluated for impairment	799		584
Loans
Individually evaluated for impairment	2,355	2,246
Collectively evaluated for impairment	114,369	112,077
Loans	116,786	114,360	114,360
Commercial, financial, & agricultural | Financial Asset Acquired with Credit Deterioration
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0
Ending balance	0
Loans
Loans	62	37
Consumer and other
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	103	96
Charge-offs	(351)	(70)
Recoveries	55	19
Provision	419	47
Ending balance	226	92
Period end amount allocated to
Individually evaluated for impairment	0		0
Collectively evaluated for impairment	138		103
Loans
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	22,559	23,322
Loans	22,750	23,322	$ 23,322
Consumer and other | Financial Asset Acquired with Credit Deterioration
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0
Ending balance	88
Loans
Loans	$ 191	$ 0

Leases - Balance Sheet Classifi

Leases - Balance Sheet Classification of Operating Lease Right-of-use Assets and Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Operating lease liabilities	$ 695
Other Assets
Operating lease right-of-use assets	692	$ 572
Other Liabilities
Operating lease liabilities	$ 695	$ 547

Leases (Details Textual)

Leases (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Operating lease cost	$ 52	$ 30
Weighted average remaining lease term	4 years 7 months 28 days
Weighted average discount rate	1.80%

Leases - Future Maturities of O

Leases - Future Maturities of Operating Lease Liabilities and Other Lease Information (Details) $ in Thousands	Mar. 31, 2020USD ($)
Lease Liability
2021	$ 245
2022	157
2023	126
2024	45
2025	45
After March 31, 2025	120
Total lease payments	738
Less: interest	(43)
Present value of lease liabilities	$ 695

Leases - Supplemental Lease Inf

Leases - Supplemental Lease Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases (cash payments)	$ 50
Operating cash flows from operating leases (lease liability reduction)	42
Operating lease right-of-use assets obtained in exchange for leases entered into during the period	$ 195

Borrowings - Summary of Other B

Borrowings - Summary of Other Borrowed Money (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Advances from Federal Home Loan Banks	$ 36,500	$ 47,000
Other borrowings	14,563	14,563
Total borrowings	$ 51,063	$ 61,563

Borrowings (Details Textual)

Borrowings (Details Textual) - USD ($) $ in Thousands	May 01, 2019	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Lendable collateral of loans		$ 103,100
Remaining credit avabailable		341,400
Outstanding balance on line of credit		0
Line of credit, current borrowing capacity		55,000
Subordinated debt		24,229	$ 24,229
Federal Reserve Bank Advances
Debt Instrument [Line Items]
Short-term debt, borrowing capacity		0
Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 10,000
Proceeds from line of credit	$ 5,300
Outstanding balance on line of credit		5,300
Revolving Credit Facility | Prime Rate
Debt Instrument [Line Items]
Basis spread on variable rate	0.40%
Term Note
Debt Instrument [Line Items]
Debt instrument, stated interest rate	4.70%
Notes payable balance		$ 9,300
Line of credit, maximum amount	$ 10,000
Minimum
Debt Instrument [Line Items]
FHLB interest rate		0.52%
Maximum
Debt Instrument [Line Items]
FHLB interest rate		3.51%

Borrowings - Aggregate Stated M

Borrowings - Aggregate Stated Maturities (Details) - Other Borrowings $ in Thousands	Mar. 31, 2020USD ($)
Long-term Debt, Fiscal Year Maturity [Abstract]
2021	$ 5,313
2022	14,000
2023	3,000
2024	9,250
2025 and After	19,500
Long-term Debt	$ 51,063

Earnings Per Share - Summary of

Earnings Per Share - Summary of Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Numerator
Net income available to common stockholders	$ 1,603	$ 2,835
Weighted average number of common shares
Outstanding for Basic Earnings Per Common Share (in shares)	9,498,783	8,440,357
Weighted-Average Number of Shares Outstanding for Diluted Earnings Per Common Share (in shares)	9,498,783	8,440,357
Earnings Per Share - Basic (in dollars per share)	$ 0.17	$ 0.34
Earnings Per Share - Diluted (in dollars per share)	$ 0.17	$ 0.34

Commitments and Contingencies -

Commitments and Contingencies - Financial Instruments Outstanding Whose Contract Amount Represents Credit Risk (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Other Commitments [Line Items]
Letters of Credit	$ 2,626	$ 1,576
Loan Origination Commitments
Other Commitments [Line Items]
Loan Commitments	$ 147,433	$ 102,890

Commitments and Contingencies_2

Commitments and Contingencies (Details Textual)	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Letter of credit, expiration date period	1 year

Fair Value of Financial Instr_3

Fair Value of Financial Instruments and Fair Value Measurements - Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Assets
Cash and short-term investments	$ 95,827	$ 104,092
Investment securities available for sale, at fair value	333,085	347,332
Other investments, at cost	3,891
Other investments, at cost		4,288
Loans held for sale	11,022	10,076
Loans, net	1,003,928	938,475
Liabilities
Deposits	1,293,076	1,294,506
Subordinated debentures	24,229	24,229
Other borrowings	48,465	60,585
Level 1
Assets
Cash and short-term investments	95,827	104,192
Investment securities available for sale, at fair value	0	0
Other investments, at cost	3,162
Other investments, at cost		3,559
Loans held for sale	0	0
Loans, net	0	0
Liabilities
Deposits	0	0
Subordinated debentures	0	0
Other borrowings	0	0
Level 2
Assets
Cash and short-term investments	0	0
Investment securities available for sale, at fair value	331,068	345,310
Other investments, at cost	729
Other investments, at cost		729
Loans held for sale	11,022	10,076
Loans, net	0	0
Liabilities
Deposits	1,293,076	1,294,506
Subordinated debentures	24,229	24,229
Other borrowings	48,465	60,585
Level 3
Assets
Cash and short-term investments	0	0
Investment securities available for sale, at fair value	2,017	2,022
Other investments, at cost	0
Other investments, at cost		0
Loans held for sale	0	0
Loans, net	1,003,928	938,475
Liabilities
Deposits	0	0
Subordinated debentures	0	0
Other borrowings		0
Carrying Value
Assets
Cash and short-term investments	95,827	104,092
Investment securities available for sale, at fair value	333,085	347,332
Other investments, at cost	3,891
Other investments, at cost		4,288
Loans held for sale	11,022	10,076
Loans, net	980,642	961,696
Liabilities
Deposits	1,293,076	1,293,742
Subordinated debentures	24,229	24,229
Other borrowings	$ 51,063	$ 61,563

Fair Value of Financial Instr_4

Fair Value of Financial Instruments and Fair Value Measurements (Details Textual) - USD ($)	3 Months Ended	6 Months Ended
	Mar. 31, 2020	Jun. 30, 2019
Fair Value Disclosures [Abstract]
Fair value input, discount amount	10.00%
Transfers out of level 3	$ 0	$ 2,009,000

Fair Value of Financial Instr_5

Fair Value of Financial Instruments and Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring and Nonrecurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	$ 333,085	$ 347,332
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	331,068	345,310
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	2,017	2,022
State, county & municipal securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	6,410	5,115
Corporate Debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	2,017	2,806
Mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	324,658	339,411
Recurring Securities Available for Sale
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	333,085
Recurring Securities Available for Sale | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	0
Recurring Securities Available for Sale | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	331,068
Recurring Securities Available for Sale | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	2,017	2,022
Recurring Securities Available for Sale | State, county & municipal securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	6,410	5,115
Recurring Securities Available for Sale | State, county & municipal securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	0	0
Recurring Securities Available for Sale | State, county & municipal securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	6,410	5,115
Recurring Securities Available for Sale | State, county & municipal securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	0	0
Recurring Securities Available for Sale | Corporate Debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	2,017	2,806
Recurring Securities Available for Sale | Corporate Debt securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	0	0
Recurring Securities Available for Sale | Corporate Debt securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	0	784
Recurring Securities Available for Sale | Corporate Debt securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	2,017	2,022
Recurring Securities Available for Sale | Mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	324,658	339,411
Recurring Securities Available for Sale | Mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	0	0
Recurring Securities Available for Sale | Mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	324,658	339,411
Recurring Securities Available for Sale | Mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Recurring Securities Available for Sale	0	0
Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Collateral Dependent Impaired Loans	4,509	5,985
Other Real Estate	847	1,320
Total nonrecurring assets	5,356	7,305
Nonrecurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Collateral Dependent Impaired Loans	0	0
Other Real Estate	0	0
Total nonrecurring assets	0	0
Nonrecurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Collateral Dependent Impaired Loans	0	0
Other Real Estate	0	0
Total nonrecurring assets	0	0
Nonrecurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Collateral Dependent Impaired Loans	4,509	5,985
Other Real Estate	847	1,320
Total nonrecurring assets	$ 5,356	$ 7,305

Fair Value of Financial Instr_6

Fair Value of Financial Instruments and Fair Value Measurements - Quantitative Information for Financial Instruments Measured at Fair Value (Details) $ in Thousands	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other Real Estate Owned	$ 847	$ 1,320
Nonrecurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Collateral Dependent Impaired Loans	4,509	5,985
Level 3 | Nonrecurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Collateral Dependent Impaired Loans	4,509	5,985
Valuation, Market Approach | Level 3 | Nonrecurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other Real Estate Owned	$ 847	$ 1,320
Valuation, Market Approach | Level 3 | Nonrecurring | Minimum | Measurement Input, Comparability Adjustment
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other Real Estate Owned, Measurement Input	0	0
Valuation, Market Approach | Level 3 | Nonrecurring | Maximum | Measurement Input, Comparability Adjustment
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other Real Estate Owned, Measurement Input	0.20	0.20
Real Estate Portfolio Segment | Commercial Construction | Valuation, Market Approach | Level 3 | Nonrecurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Collateral Dependent Impaired Loans		$ 5,985
Real Estate Portfolio Segment | Commercial Construction | Valuation, Market Approach | Level 3 | Nonrecurring | Minimum | Measurement Input, Comparability Adjustment
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Collateral Dependent Impaired Loans, Weighted Average Discount Range		0
Real Estate Portfolio Segment | Commercial Construction | Valuation, Market Approach | Level 3 | Nonrecurring | Maximum | Measurement Input, Comparability Adjustment
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Collateral Dependent Impaired Loans, Weighted Average Discount Range		0.20
Real Estate Portfolio Segment | Residential | Valuation, Market Approach | Level 3 | Nonrecurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Collateral Dependent Impaired Loans	$ 4,509
Real Estate Portfolio Segment | Residential | Valuation, Market Approach | Level 3 | Nonrecurring | Minimum | Measurement Input, Comparability Adjustment
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Collateral Dependent Impaired Loans, Weighted Average Discount Range	0.10
Real Estate Portfolio Segment | Residential | Valuation, Market Approach | Level 3 | Nonrecurring | Maximum | Measurement Input, Comparability Adjustment
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Collateral Dependent Impaired Loans, Weighted Average Discount Range	0.50

Fair Value of Financial Instr_7

Fair Value of Financial Instruments and Fair Value Measurements - Fair Value Measurement Using Significant Unobservable Inputs (Details) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Transfers out of Level 3	$ 0		$ (2,009,000)
Available-for-sale Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, Beginning	2,022,000	$ 4,277,000	$ 4,277,000
Transfers out of Level 3	0	0
Sales	0	0
Paydowns	(5,000)	(390,000)
Realized Loss on Sale of Security	0	0
Unrealized gains included in Other Comprehensive Income	0	10,000
Balance, Ending	$ 2,017,000	$ 3,897,000

Fair Value of Financial Instr_8

Fair Value of Financial Instruments and Fair Value Measurements - Quantitative Information About Recurring Level 3 Fair Value Measurement (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Investment securities available for sale, at fair value	$ 333,085	$ 347,332
Recurring Securities Available for Sale
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Investment securities available for sale, at fair value	333,085
Level 3
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Investment securities available for sale, at fair value	2,017	2,022
Level 3 | Recurring Securities Available for Sale
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Investment securities available for sale, at fair value	$ 2,017	$ 2,022

Segment Information - Schedule

Segment Information - Schedule of Segment Reporting Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Segment Reporting Information [Line Items]
Net Interest Income	$ 12,704	$ 10,357
Provision for loan losses	1,956	131
Noninterest Income	4,561	2,334
Noninterest Expenses	13,378	9,026
Income taxes	328	699
Segment Profit (Loss)	1,603	2,835
Segment Assets	1,510,048	1,515,313	$ 1,515,313
Bank
Segment Reporting Information [Line Items]
Net Interest Income	12,656	10,357
Provision for loan losses	1,956	131
Noninterest Income	3,049	2,334
Noninterest Expenses	11,667	9,026
Income taxes	368	699
Segment Profit (Loss)	1,714	2,835
Segment Assets	1,497,788	1,503,284
Mortgage Banking
Segment Reporting Information [Line Items]
Net Interest Income	34	0
Provision for loan losses	0	0
Noninterest Income	1,253	0
Noninterest Expenses	1,195	0
Income taxes	11	0
Segment Profit (Loss)	81	0
Segment Assets	11,082	11,624
Small Business Specialty Lending Division
Segment Reporting Information [Line Items]
Net Interest Income	14	0
Provision for loan losses	0	0
Noninterest Income	259	0
Noninterest Expenses	516	0
Income taxes	(51)	0
Segment Profit (Loss)	(192)	0
Segment Assets	$ 1,178	$ 405

Regulatory Capital Matters (Det

Regulatory Capital Matters (Details Textual)	Jan. 01, 2016
Banking and Thrift [Abstract]
Percentage of risk-weighted assets	0.625%
Increase in percentage of risk-weighted assets	0.625%
Final level of percentage of risk-weighted assets	2.50%

Regulatory Capital Matters - Su

Regulatory Capital Matters - Summary of Regulatory Capital Information (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Total Capital to Risk-Weighted Assets
Actual Amount	$ 138,789	$ 140,973
Actual Ratio	13.47%	13.17%
For Capital Adequacy Purposes, Amount	$ 82,429	$ 85,661
For Capital Adequacy Purposes, Ratio	8.00%	8.00%
Tier I Capital to Risk-Weighted Assets
Actual Amount	$ 132,189	$ 134,110
Actual Ratio	12.68%	12.52%
For Capital Adequacy Purposes, Amount	$ 62,550	$ 64,246
For Capital Adequacy Purposes, Ratio	6.00%	6.00%
Common Equity Tier I Capital to Risk-Weighted Assets
Actual Amount	$ 108,689	$ 110,610
Actual Ratio	10.47%	10.33%
For Capital Adequacy Purposes, Amount	$ 46,714	$ 48,185
For Capital Adequacy Purposes, Ratio	4.50%	4.50%
Tier I Capital to Average Assets
Actual Amount	$ 132,189	$ 134,110
Actual Ratio	9.06%	8.92%
For Capital Adequacy Purposes, Amount	$ 58,362	$ 60,141
For Capital Adequacy Purposes, Ratio	4.00%	4.00%
Colony Bank
Total Capital to Risk-Weighted Assets
Actual Amount	$ 148,961	$ 151,444
Actual Ratio	13.98%	14.19%
For Capital Adequacy Purposes, Amount	$ 85,242	$ 85,407
For Capital Adequacy Purposes, Ratio	8.00%	8.00%
To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount	$ 106,553	$ 106,758
To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio	10.00%	10.00%
Tier I Capital to Risk-Weighted Assets
Actual Amount	$ 140,577	$ 144,581
Actual Ratio	13.19%	13.54%
For Capital Adequacy Purposes, Amount	$ 63,947	$ 64,055
For Capital Adequacy Purposes, Ratio	6.00%	6.00%
To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount	$ 85,263	$ 8,547
To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio	8.00%	8.00%
Common Equity Tier I Capital to Risk-Weighted Assets
Actual Amount	$ 140,577	$ 144,581
Actual Ratio	13.19%	13.54%
For Capital Adequacy Purposes, Amount	$ 47,960	$ 48,041
For Capital Adequacy Purposes, Ratio	4.50%	4.50%
To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount	$ 69,276	$ 69,393
To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio	6.50%	6.50%
Tier I Capital to Average Assets
Actual Amount	$ 140,577	$ 144,581
Actual Ratio	9.46%	9.77%
For Capital Adequacy Purposes, Amount	$ 59,441	$ 59,977
For Capital Adequacy Purposes, Ratio	4.00%	4.00%
To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount	$ 74,301	$ 74,972
To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio	5.00%	5.00%

Subsequent Events (Details)

Subsequent Events (Details) - $ / shares	Apr. 22, 2020	Mar. 31, 2020	Mar. 31, 2019
Subsequent Event [Line Items]
Dividends declared (in dollars per share)		$ 0.075	$ 0.10
Subsequent Event
Subsequent Event [Line Items]
Dividends declared (in dollars per share)	$ 0.10